0001144204-16-130353.txt : 20161031 0001144204-16-130353.hdr.sgml : 20161031 20161028180001 ACCESSION NUMBER: 0001144204-16-130353 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161031 DATE AS OF CHANGE: 20161028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED SURGICAL SYSTEMS INC CENTRAL INDEX KEY: 0000894871 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680232575 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12471 FILM NUMBER: 161959673 BUSINESS ADDRESS: STREET 1: 401 WILSHIRE BLVD., STREET 2: 12TH FLOOR CITY: SANTA MONICA, STATE: CA ZIP: 90401 BUSINESS PHONE: 310-526-5000 MAIL ADDRESS: STREET 1: 401 WILSHIRE BLVD., STREET 2: 12TH FLOOR CITY: SANTA MONICA, STATE: CA ZIP: 90401 10-Q 1 v451112_10q.htm FORM 10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended September 30, 2016

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission file number 1-12471

 

INTEGRATED SURGICAL SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 68-0232575
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
   
2425 Cedar Springs Road  
Dallas, Texas 75201
(Address of principal executive offices) (Zip Code)

 

(310) 526-5000

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:   None

 

Securities registered pursuant to Section 12(g) of the Act:   Common Stock $0.01 par value

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ¨     No  þ

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ¨     No  þ

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 

Yes þ     No  ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  þ     No  ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer ¨ Accelerated filer ¨
   
Non-accelerated filer ¨ (Do not check if a smaller reporting company) Smaller reporting company þ

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes þ or No ¨

 

As of October 21, 2016, the Registrant had 9,530,379 shares of common stock outstanding.

 

 

 

 

Integrated Surgical Systems, Inc.

 

Form 10-Q

For the nine and three months ended September 30, 2016

 

Table of Contents

 

        Page
Part I. Financial Information    
         
Item 1.   Condensed Financial Statements   2
         
    Balance Sheets at September 30, 2016 (unaudited) and December 31, 2015   2
         
    Statements of Comprehensive Loss (unaudited) for the nine months ended September 30, 2016 and 2015   3
         
    Statements of Comprehensive Loss (unaudited) for the three months ended September 30, 2016 and 2015   4
         
    Statements of Cash Flows (unaudited) for the nine months ended September 30, 2016 and 2015   5
         
    Statement of Changes in Stockholders’ Equity (unaudited) for the nine months ended September 30, 2016   6
         
    Notes to Condensed Financial Statements (unaudited)   7
         
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   14
         
Item 3.   Quantitative and Qualitative Disclosures About Market Risk   16
         
Item 4.   Controls and Procedures   16
         
Part II. Other Information    
         
Item 1.   Legal Proceedings   18
         
Item 1a.   Risk Factors   18
         
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds   18
         
Item 3.   Defaults Upon Senior Securities   18
         
Item 4.   Mine Safety Disclosures   18
         
Item 5.   Other Information   18
         
Item 6.   Exhibits   19
         
Signatures   20

 

 

 

 

Part I. Financial Information

 

Item 1. Condensed Financial Statements 

 

Integrated Surgical Systems, Inc.

Condensed Balance Sheets

 

   September 30,   December 31, 
   2016   2015 
   (Unaudited)     
Assets          
           
Current assets:          
Cash and cash equivalents  $479,187   $545,705 
Investments in available-for-sale securities   1,097,470    1,776,185 
Notes receivable   638,351    - 
Other current assets   42,846    29,928 
Total current assets   2,257,854    2,351,818 
           
Total Assets  $2,257,854   $2,351,818 
           
Liabilities and stockholders’ equity          
           
Current liabilities:          
Accounts payable  $68,984   $9,631 
Conversion feature liability   88,395    76,343 
Total current liabilities   157,379    85,974 
           
Commitments and contingencies          
           
Redeemable convertible preferred stock, $0.01 par value, 1,000,000 shares authorized; 168 shares issued and outstanding ($168,496 aggregate liquidation value)   168,496    168,496 
           
Stockholders’ equity:          
Common stock, $0.01 par value, 100,000,000 shares authorized; 9,483,503 and 9,282,981 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively   94,835    92,829 
Common stock to be issued   9,375    12,500 
Additional paid-in capital   64,543,421    64,514,177 
Accumulated deficit   (62,738,143)   (62,527,454)
Accumulated other comprehensive income   22,491    5,296 
Total stockholders’ equity   1,931,979    2,097,348 
Total liabilities and stockholders’ equity  $2,257,854   $2,351,818 

 

See accompanying notes to condensed financial statements

 

 2 

 

 

Integrated Surgical Systems, Inc.

Condensed Statements of Comprehensive Loss

(Unaudited)

 

   Nine Months ended
September 30,
 
   2016   2015 
         
Operating Expenses          
           
General and administrative expenses  $220,900   $179,694 
           
Loss from operations   (220,900)   (179,694)
           
Other income (expense)          
Interest and dividend income, net   20,188    25,710 
Change in fair value of conversion feature   (12,052)   (11,001)
Realized gain on available-for-sale securities   2,875    1,734 
Total other income   11,011    16,443 
           
Loss before income taxes   (209,889)   (163,251)
           
Income taxes   800    800 
           
Net loss  $(210,689)  $(164,051)
           
Other comprehensive income (loss)          
           
Unrealized gain (loss) on available-for-sale securities before reclassification, net of tax   20,070    (2,883)
           
Reclassification adjustment for gains, net of tax   (2,875)   (1,879)
           
Other comprehensive income (loss)   17,195    (4,762)
           
Comprehensive loss  $(193,494)  $(168,813)
           
Loss per share:          
Basic  $(0.02)  $(0.02)
Diluted  $(0.02)  $(0.02)
           
Weighted average number of shares outstanding          
Basic   9,416,859    9,107,461 
Diluted   9,416,859    9,107,461 

 

See accompanying notes to condensed financial statements

 

 3 

 

 

Integrated Surgical Systems, Inc.

Condensed Statements of Comprehensive Loss

(Unaudited)

 

   Three Months ended
September 30,
 
   2016   2015 
         
Operating Expenses          
           
General and administrative expenses  $102,009   $49,640 
           
Loss from operations   (102,009)   (49,640)
           
Other income (expense)          
Interest and dividend income, net   10,637    7,765 
Change in fair value of conversion feature   (2,858)   (10,463)
Realized gain on available-for-sale securities   68    217 
Total other income   7,847    (2,481)
           
Net loss  $(94,162)  $(52,121)
           
Other comprehensive income (loss)          
           
Unrealized gain (loss) on available-for-sale securities before reclassification, net of tax   4,036    (3,370)
           
Reclassification adjustment for gains, net of tax   (68)   (217)
           
Other comprehensive income (loss)   3,968    (3,587)
           
Comprehensive loss  $(90,194)  $(55,708)
           
Loss per share:          
    Basic  $(0.01)  $(0.01)
    Diluted  $(0.01)  $(0.01)
           
Weighted average number of shares outstanding          
Basic   9,476,497    9,190,589 
Diluted   9,476,497    9,190,589 

 

See accompanying notes to condensed financial statements

 

 4 

 

 

Integrated Surgical Systems, Inc.

Condensed Statements of Cash Flows

(Unaudited)

 

   Nine Months ended
September 30,
 
   2016   2015 
Cash flows from operating activities:          
Net loss  $(210,689)  $(164,051)
Adjustments to reconcile net loss to net cash used in operating activities:          
Change in fair value of conversion feature   12,052    11,001 
Stock based compensation   28,125    37,500 
Realized gains on available-for-sale securities   (2,875)   (1,734)
Changes in operating assets and liabilities:          
Other current assets   (12,918)   (9,792)
Accounts payable and accrued liabilities   59,353    (8,474)
Net cash used in operating activities   (126,952)   (135,550)
           
Cash flows from investing activities:          
Notes receivable   (638,351)   - 
Purchases of available for sale securities   -    (1,221,185)
Proceeds received from sales of available-for-sale securities   -    9,200 
Proceeds received from maturities of available-for-sale securities   698,785    1,146,754 
Net cash provided by (used in) investing activities   60,434    (65,231)
           
Net decrease in cash and cash equivalents   (66,518)   (200,781)
           
Cash and cash equivalents at beginning of period   545,705    542,215 
           
Cash and cash equivalents at end of period  $479,187   $341,434 
           
Supplemental non-cash disclosure:          
Unrealized gain (loss) on available-for-sale securities  $17,195   $(4,762)

 

See accompanying notes to condensed financial statements

  

 5 

 

 

Integrated Surgical Systems, Inc.

Condensed Statement of Changes in Stockholders’ Equity (unaudited)

 

                       Accumulated         
           Common Stock   Additional   Other       Total 
   Common Stock   To Be Issued   Paid-in   Comprehensive   Accumulated   Stockholders’ 
   Shares   Amount   Shares   Amount   Capital   Income   Deficit   Equity 
                                 
Balance at December 31, 2015   9,282,981   $92,829    83,334   $12,500   $64,514,177   $5,296   $(62,527,454)  $2,097,348 
Stock-based compensation   200,522    2,006    (83,334)   (12,500)   29,244    -    -    18,750 
Common stock to be issued   -    -    46,876    9,375    -    -    -    9,375 
Comprehensive income (loss)                                        
Net loss   -    -    -    -    -    -    (210,689)   (210,689)
Other Comprehensive income                                        
Net unrealized gain on investment in securities   -    -    -   -    -    17,195    -   17,195 
Comprehensive income (loss)   -    -    -    -    -    17,195    (210,689)   (193,494)
                                         
Balance at September 30, 2016   9,483,503   $94,835    46,876   $9,375   $64,543,421   $22,491   $(62,738,143)  $1,931,979 

 

See accompanying notes to condensed financial statements

 

 6 

 

 

Integrated Surgical Systems, Inc.

Notes to Condensed Financial Statements (unaudited)

 

1. Organization and Operations

 

Integrated Surgical Systems, Inc. (the “Company”) was incorporated in Delaware in 1990 to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures.  On June 28, 2007, the Company completed the sale of substantially all of its operating assets.  After completion of the sale, the Company no longer engaged in any business activities related to its former business, described above. The Company’s current operations are limited to completing a business combination or strategic alliance.

 

As of September 20, 2016, the Company signed a letter of intent to pursue the acquisition of theMaven Network, Inc. and on October 14, 2016, it signed a share exchange agreement with theMaven Network, Inc. and its shareholders to acquire the company as a wholly owned subsidiary. The closing is expected to take place within a few weeks, but before December 31, 2016.

 

If the Company does not complete the above mentioned acquisition of theMaven Network, Inc., then the Company does not have an estimate as to when it will complete a qualified merger, acquisition, or strategic alliance. There is no assurance that such opportunities will be available, or if available, upon favorable terms. If the Company is unsuccessful in completing a suitable merger, acquisition or strategic alliance, then the Board of Directors may liquidate the Company and distribute all its remaining assets, which consist primarily of cash and available-for-sale securities, to its stockholders.

 

The Company believes that if it identifies and completes a suitable merger, acquisition or strategic alliance target, it may need additional capital to complete the transaction or fund the continuing acquired operations. The Company, at this time, cannot estimate the amount of financing it may need for a transaction. There is no assurance that it will be able to obtain any required funding for a transaction, or that if it is obtainable it will be on acceptable terms.

 

2. Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements and related notes have been prepared in accordance with the rules and regulations under Regulation S-X of the Securities and Exchange Commission for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed balance sheet at December 31, 2015 has been derived from the Company’s audited financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to present fairly the financial position as of September 30, 2016, the results of operations and cash flows for the nine months then ended have been included. These condensed financial statements should be read in conjunction with the financial statements of the Company and the Company’s management discussion and analysis included in the Company’s Form 10-K for the year ended December 31, 2015. Interim results are not necessarily indicative of the results for a full year.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.  Actual results could materially differ from those estimates.

 

 7 

 

 

Cash and Cash Equivalents

 

Cash and cash equivalents include checking and money market accounts held in two financial institutions. The Company has a checking account at one institution with a balance of approximately $303,000 at September 30, 2016. The funds in this account are fully guaranteed by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company has a brokerage account with a second financial institution, with a cash balance of approximately $176,000 at September 30, 2016. Assets in this brokerage account are protected by the Securities Investor Protection Corporation (“SIPC”) up to $500,000 (with a limit of $250,000 for cash).   Throughout the year, the account balances at these institutions periodically exceed FDIC and SIPC insurance coverage; however, the Company has not experienced losses in these accounts and believes it is not exposed to any significant credit risk.

 

Stock-Based Compensation

 

Compensation costs for stock, warrants or options issued to employees and non-employees are based on the fair value method and accounted for in accordance with FASB ASC 718, ” Compensation – Stock Compensation.”  The value of warrants and options are calculated using a Black-Scholes Model, using the market price of the Company’s common stock on the date of issuance for the employee options or warrants and the date of commitment for non-employee options or warrants, an expected dividend yield of zero, the expected life of the warrants or options and the expected volatility of the Company’s common stock.

 

Investments in Available-for-Sale Securities

 

The Company has a portfolio of investments in available-for-sale debt securities, which consist of fixed income debt securities, and which are accounted for in accordance with FASB ASC 320, “Investments - Debt and Equity Securities.”  Management determines the appropriate classification of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date.  Available-for-sale securities are stated at fair value, and unrealized holding gains and losses, net of the related deferred tax effect, if any, are reported as other comprehensive income, a separate component of stockholders’ equity.

 

Fair Value Measurement

 

FASB ASC 820 “Fair Value Measurements and Disclosures” clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, FASB ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

 

·Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

·Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.

 

·Level 3 - Unobservable inputs which are supported by little or no market activity.

 

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

 

In accordance with FASB ASC 820, the Company measures its cash equivalents, investments in available-for-sale securities, and derivative liability at fair value. The company classifies its cash equivalents and investments in available for sale securities within Level 1 or Level 2 in the fair value hierarchy because the company uses quoted market prices or alternative pricing sources and models utilizing observable market inputs to determine their fair value. The Company’s derivative liability is classified within Level 3.

 

The carrying value of other current assets and liabilities are considered to be representative of their respective fair values because of the short-term nature of those instruments.

 

 8 

 

 

Income Taxes

 

Deferred income taxes have been provided for temporary differences between financial statement and income tax reporting under the liability method, using expected tax rates and laws that are expected to be in effect when the differences are expected to reverse.  A valuation allowance is provided when realization is not considered more likely than not.

 

The Company applies the provisions of FASB ASC 740, “Income Taxes.”  ASC 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 

The Company’s policy is to classify expenses as a result of income tax assessments as interest expense for interest charges and as penalties in general and administrative expenses for penalty assessments.

 

Recently Issued Accounting Pronouncements

  

Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

 

3.  Income (Loss) Per Share

 

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period plus dilutive common stock equivalents, using the treasury stock method.

 

Common stock equivalents for convertible preferred stock of 1,101,281 and 1,321,537 shares were excluded from the calculation of loss per share for the nine months and three months ended September 30, 2016 and 2015, respectively, because they were not dilutive; these shares would have been dilutive if the Company had not had a net loss for the these periods.

 

Stock options for the purchase of 175,000 and 200,000 shares of the Company’s common stock were excluded from the calculation of income per share for the nine months and three months ended September 30, 2016 and 2015, respectively, because they were anti-dilutive.

 

4.  Notes Receivable

 

The Company has the following notes receivable:

 

Issue Date

  September 30, 2016
(Unaudited)
   December 31, 2015 
August 11, 2016  $155,451   $     - 
September 14, 2016   357,900    - 
September 26, 2016   125,000    - 
   $638,351   $- 

 

On August 11, 2016, the Company entered into a term note agreement (“Term Note”) with theMaven Network, Inc. (“Borrower”) for a loan of $150,000, plus expenses incurred by the Company in connection with the execution of this term note. The note is due at the earlier of (1) February 13, 2017, or (ii) the occurrence of certain events, as defined in the agreement. The note is secured by a personal guarantee of the principal officer of the Borrower (“Borrower Officer”). The $150,000 amount was guaranteed by MDB until the extension of additional principal as described below. The principal amount as of August 11, 2016, including expenses incurred by the Company, is $155,451. The Term Note provides that the principal amount of the loan would be increased by $350,000 (“Additional Amount”), plus expenses incurred by the Company in connection with the Term Note, if and when the Borrower Officer provides additional security for the total loan amount in the form of a mortgage on certain real estate (the “Mortgage”).  The Mortgage was provided in late August and the Company subsequently extended the Additional Amount to Borrower.  The interest rate on the borrowed amount is 8% per annum.  The loan agreement contains additional covenants, representations and events of default.

 

 9 

 

 

The Term Note was amended on August 25, 2016 to provide details of the Mortgage.  The Term Note was further amended on September 26, 2016 to extend an additional $125,000 to the Borrower.  This additional $125,000 of principle is guaranteed by MDB. As of September 30, 2016, the aggregated principal amount under the Term Note, including expenses incurred by the Company, is $638,351.

 

5.  Investment in Available-for-Sale Securities

 

The following is a summary of the Company’s investments in available-for-sale securities as of September 30, 2016 (unaudited):

 

   Cost   Unrealized
Gains
   Unrealized
Losses
   Fair Value 
U.S. federal agency securities  $4,898   $53   $-   $4,951 
Municipal securities   311,517    1,582    (236)   312,863 
Certificates of deposit   741,769    31,612    (10,736)   762,645 
Corporate debt securities   16,795    216    -    17,011 
   $1,074,979   $33,463   $(10,972)  $1,097,470 

 

The following is a summary of the Company’s investments in available-for-sale securities as of December 31, 2015:

 

   Cost   Unrealized
Gains
   Unrealized
Losses
   Fair Value 
U.S. federal agency securities  $4,830   $55   $-   $4,885 
Municipal securities   492,237    789    (980)   492,046 
Certificates of deposit   1,256,649    20,182    (14,865)   1,261,966 
Corporate debt securities   17,173    115    -    17,288 
   $1,770,889   $21,141   $(15,845)  $1,776,185 

   

The cost and fair value of investments in fixed income available-for-sale debt securities, by contractual maturity, as of September 30, 2016 (unaudited), are as follows:

 

   Cost   Fair
Value
 
Due within one year  $739,361   $757,136 
Due after one year through three years   164,331    165,934 
Due after three years   171,287    174,400 
   $1,074,979   $1,097,470 

 

Expected maturities will differ from contractual maturities because the issuers of certain debt securities have the right to call or prepay their obligations without any penalties.  The Company has classified the entire fair value of its investments in available-for-sale debt securities as current assets in the accompanying condensed balance sheets.

 

6.  Redeemable Convertible Preferred Stock and Conversion Feature Liability

 

The Company’s Certificate of Incorporation authorized 1,000,000 shares of undesignated, serial preferred stock. Preferred stock may be issued from time to time in one or more series. The Board of Directors is authorized to determine the rights, preferences, privileges, and restrictions granted to and imposed upon any wholly unissued series of preferred stock and designation of any such series without any further vote or action by the Company’s stockholders.

 

 10 

 

 

As of September 30, 2016 and December 31, 2015, the Company’s only outstanding series of convertible preferred stock is the Series G Convertible Preferred Stock (“Series G”).

 

The Series G stock has a stated value of $1,000 per share, and is convertible into common stock at a conversion price equal to 85% of the lowest sale price of the common stock on its listed market over the five trading days preceding the date of conversion (“Beneficial Conversion Feature”), subject to a maximum conversion price. The number of shares of common stock that may be converted is determined by dividing the stated value of the number of shares of Series G to be converted by the conversion price. The Company may elect to pay the Series G holder in cash at the current market price multiplied by the number of shares of common stock issuable upon conversion.

 

For the nine months ended September 30, 2016 and the year ended December 31, 2015, no shares of Series G were converted into shares of common stock.  At September 30, 2016 and December 31, 2015, the outstanding Series G shares were convertible into a minimum of 1,101,281 and 1,321,537 shares of common stock, respectively.

 

Upon a change in control, sale of or similar transaction, as defined in the Certificate of Designation for the Series G, each holder of the Series G has the option to deem such transaction as a liquidation and may redeem his or her shares at the liquidation value of $1,000, per share, for an aggregate amount of $168,496.  The sale of all the assets on June 28, 2007 triggered the preferred stockholders’ redemption option.  As such redemption is not in the control of the Company, the Series G stock has been accounted for as if it was redeemable preferred stock and is classified on the balance sheet between liabilities and stockholders’ equity.

 

The conversion feature of the preferred stock is considered a derivative according to ASC 815 “Derivatives and Hedging”, therefore, the fair value of the derivative is reflected in the financial statements as a liability, which was determined to be $88,395 as of September 30, 2016 (unaudited), and has been included as “conversion feature liability” on the accompanying condensed balance sheets. As of December 31, 2015, the fair value of the derivative was determined to be $76,343.

 

The fair value of the conversion feature liability is calculated under a Black-Scholes Model, using the market price of the Company’s common stock on each of the balance sheet dates presented, the expected dividend yield, the expected life of the redemption and the expected volatility of the Company’s common stock.

 

The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and considering factors specific to the conversion feature liability. Since some of the assumptions used by the Company are unobservable, the conversion feature liability is classified within the level 3 hierarchy in the fair value measurement.

 

The expected volatility of the conversion feature liability was based on the historical volatility of the Company’s common stock. The expected life assumption was based on the expected remaining life of the underlying preferred stock redemption. The risk-free interest rate for the expected term of the conversion feature liability was based on the average market rate on U.S. treasury securities in effect during the applicable quarter. The dividend yield reflected historical experience as well as future expectations over the expected term of the underlying preferred stock redemption. Therefore, the fair value of the conversion feature liability is sensitive to changes in above assumptions and changes of the Company’s common stock price.

 

The table below shows the quantitative information about the significant unobservable inputs used in the fair value measurement of level 3 conversion feature liability:

 

   September 30, 2016 
   (unaudited) 
     
Expected remaining life of the redemption in years   1.0 
Risk free interest rate   0.59%
Expected annual volatility   77.70%
Annual rate of dividends   0%

 

 11 

 

 

The changes in the fair value of the derivative are as follows:

 

Balance as of January 1, 2016  $76,343 
Decrease of fair value   12,052 
      
Ending balance as of September 30, 2016 (unaudited)  $88,395 

 

7.  Stock-based compensation

 

For the nine months ended September 30, 2016, the Company had no activity related to stock options. As of September 30, 2016, a summary of options outstanding under the Company’s 2014 options grant was as follows:

 

Range of
Exercise
Price
   Weighted-
Average Remaining
Contractual Life (Years)
   Number
Outstanding
   Weighted-
Average
Exercise
Price
   Number
Exercisable
   Weighted-
Average
Exercise
Price
 
$0.17    2.63    175,000   $0.17    175,000   $0.17 

 

The Company agreed to compensate each director in the amount of $25,000 per year, payable quarterly, beginning on January 1, 2016. Such compensation may be paid to each director either in the form of cash, or the Company’s common stock or a combination thereof at the election of such director which may be changed during the year with respect to future payments. The Company compensated one of its directors by issuing common stock, one of its directors by issuing common stock and in cash, and the third director in cash for services rendered in 2016. The Company compensated two of its four directors by issuing common stock, and two directors in cash for services rendered in 2015. The number of shares issued to each director was determined based upon the equivalent cash compensation accrued divided by the closing price of the Company’s common stock on the date that the compensation is fully earned each quarter, which is the last day of such quarter. The Company recorded stock-based compensation expense of $9,375 and $28,125 for the three and nine months ended September 30, 2016 for two directors, which was recorded as common stock to be issued.

 

On January 11, 2016, the Company issued 41,667 shares of common stock to each of two directors as compensation for the three months ended December 31, 2015. These shares, totaling 83,334, were valued at a per share price of $0.15, or a total of $12,500.

 

On April 12, 2016, the Company issued 39,063 shares of common stock to one director, and 19,531 shares of common stock to a second director as compensation for the three months ended March 31, 2016. These shares, totaling 58,594, were valued at a per share price of $0.16, or a total of $9,375 (unaudited).

  

On July 11, 2016, the Company issued 39,063 shares of common stock to one director, and 19,531 shares of common stock to a second director as compensation for the three months ended June 30, 2016. These shares, totaling 58,594, were valued at a per share price of $0.16, or a total of $9,375 (unaudited).

 

On October 4, 2016, the Company issued 31,251 shares of common stock to one director, and 15,625 shares of common stock to a second director as compensation for the three months ended September 30, 2016. These shares, totaling 46,876, were valued at a per share price of $0.20, or a total of $9,375 (unaudited).

 

 12 

 

 

8.  Related Party Transactions

 

The Company entered into an Investment Banking Advisory Services agreement in November 2007 with MDB Capital Group LLC (“MDB”), and the parties extended this agreement indefinitely in April 2009.  The agreement may be terminated by either party upon 30-days written notice.

 

The Company has a securities investment account with MDB, consisting of (a) available-for-sale investments totaling $1,097,470, that include short-term federal securities of $4,951, and certificates of deposit, municipal securities and corporate debt securities totaling $1,092,519 at September 30, 2016 (unaudited), and (b) available-for-sale investments totaling $1,776,185, that include short-term federal securities of $4,885, certificates of deposit, municipal securities and corporate debt securities totaling $1,771,300 at December 31, 2015.

 

Mr. Christopher Marlett, the Chief Executive Officer and director of the Company, is also the Chief Executive Officer of MDB. Mr. Gary Schuman, who is the Chief Financial Officer of the Company, is also the Chief Financial Officer and Chief Compliance Officer of MDB.  The Company compensates for Mr. Schuman’s services in the amount of $3,000 per month, totaling $27,000 for the nine months ended September 30, 2016 and 2015 (unaudited).  Mr. Robert Levande, who is an officer and director of the Company, is also a senior managing director of MDB. In addition to shares of common stock (as discussed in Note 6), Mr. Levande was compensated $9,375 for his services as director for the nine months ended September 30, 2016 (unaudited).

 

MDB has guaranteed $125,000 of the principle amount due on the Term Note from theMaven Network, Inc. described in Note 4 above. This guarantee will terminate upon the completion of the acquisition of theMaven Network, Inc. which is described in Note 1 above and Note 10 below.

 

9.  Commitments and Contingencies

 

From time to time, the Company may be subject to other claims and litigation arising in the ordinary course of business.  The Company is not currently a party to any legal proceedings that it believes would reasonably be expected to have a material adverse effect on the Company’s business, financial condition or results of operations.

 

The Company may have a liability for additional state franchise taxes payable in the amount of approximately $44,000, plus interest at 18% per annum, for the years 2008-2014. Because of state statutory provisions, the underpaid amount will only be due once assessed and demanded by the state.  The tax liability and associated interest has not been included as an accrued liability because management has determined that the likelihood of the state making the assessment is low.  Depending on circumstances, management may change its estimate of the probability of an assessment and establish either an accrual or record a payment for the tax liability if assessed.

 

10.  Subsequent Events

 

On October 14, 2016, the Company entered into a share exchange agreement under which the company will acquire theMaven Network, Inc. (“Maven”) in an exchange of shares, whereby Maven will become a wholly owned subsidiary of the Company.  The number of shares of the Company to be issued for the equity of Maven will be determined by a formula, and it is anticipated that the Company will issue approximately 55% of its issued and outstanding common stock immediately after the transaction.  At the closing, it is agreed that one of Maven’s directors will become a director of the Company and several of their officers will also become officers of the Company under their current employment arrangements. The consummation of the acquisition is subject to various conditions precedent, as defined in the agreement, for each of the parties to the agreement. The Company anticipates the closing taking place within a few weeks.

 

 13 

 

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

The discussion in this Quarterly Report on Form 10-Q contains forward-looking statements. Such forward-looking statements are based on current expectations, estimates and projections and certain assumptions made by management of Integrated Surgical Systems, Inc. (the “Company”). Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “could,” “would,” “may,” “on target,” “envisions,” and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict; therefore, actual results may differ materially from those expressed or forecasted in any such forward-looking statements. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. However, readers should carefully review the risk factors set forth in other reports or documents the Company files from time to time with the Securities and Exchange Commission (“SEC”), particularly the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K.

 

The following discussion should be read in conjunction with the unaudited financial statements and notes thereto in Part I, Item 1 of this Quarterly Report on Form 10-Q and with the audited financial statements and Notes thereto, and Management’s Discussion and Analysis of Financial Condition and Results of Operations that are included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2015 as filed with the SEC.

 

Overview

 

The Company was founded to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures. On June 28, 2007, the Company completed the sale of substantially all of its assets.  After the sale, the Company became inactive, and it is no longer engaged in any business activities related to its former business.  The Company’s current operations are limited to completing a business combination or strategic alliance.

 

As of September 30, 2016, the Company had no employees, and the Company relies on outside contractors to perform basic and necessary services.

 

Results of Operations

 

Nine Months Ended September 30, 2016 and 2015

 

For the nine months ended September 30, 2016 and 2015, the Company had a net loss of $210,689 and $164,051, respectively. The increase in net loss was due primarily to an increase in certain administrative expenses and a decrease in net interest income, and offset by an increase in the change in fair value of the conversion feature liability versus the prior period and by a decrease in director compensation in the current period versus the prior period. General and administrative expenses were $220,900 and $179,694 for the nine months ended September 30, 2016 and 2015, respectively. The increase in administrative expenses is due primarily to an increase in legal expenses of approximately $43,400 related to potential acquisition opportunities, offset by a decrease of approximately $12,500 of director compensation expense compared to the same period in 2015. The Company had a realized gain in available-for-sale securities for the nine months ended September 30, 2016 of approximately $2,900, and a realized gain for the nine months ended September 30, 2015 of approximately $1,700. Net interest income decreased by approximately $5,500 in the nine months ended September 30, 2016 compared to the nine months ended September 30, 2015. Change in fair value of conversion feature was an increase of approximately $12,100 for the nine months ended September 30, 2016, due to the change in fair value of the conversion feature of the Company’s convertible preferred stock; the change in value was an increase of approximately $11,000 for the same period in 2015.

 

 

 14 

 

  

Three Months Ended September 30, 2016 and 2015

 

For the three months ended September 30, 2016 and 2015, the Company had a net loss of $94,162 and $52,121, respectively. The increase in net loss was due primarily to an increase in certain administrative expenses in the current period versus the prior period, offset by a decrease in the change in fair value of the conversion feature liability versus the prior period. General and administrative expenses were $102,009 and $49,640 for the three months ended September 30, 2016 and 2015, respectively. The increase in administrative expenses is due primarily to the increase of approximately $42,800 of legal expense related to potential acquisition opportunities compared to the same period in 2015. The Company had a realized gain in available-for-sale securities for the three months ended September 30, 2016 of approximately $100, and a realized gain for the three months ended September 30, 2015 of approximately $200. Net interest income increased by approximately $2,900 in the three months ended September 30, 2016 compared to the three months ended September 30, 2015. Change in fair value of conversion feature was a increase of approximately $2,900 for the three months ended September 30, 2016, due to the change in fair value of the conversion feature of the Company’s convertible preferred stock; the change in value was an increase of approximately $10,500 for the same period in 2015.

 

Liquidity and Capital Resources

 

The Company believes that existing cash, cash equivalents, and short-term available-for-sale securities will provide sufficient working capital for the Company to meet its operating plan for the next twelve months, assuming no acquisition or other combination event being consummated.  The Board of Directors, including a director as its Chief Executive Officer, another director as its Secretary, and the Chief Financial Officer of a related party as the Company’s Chief Financial Officer assist the Company with its continuing obligations under the federal securities laws and assist with the Company’s plan to evaluate various merger, acquisition, or strategic alliance opportunities. None of these individuals receive additional compensation, other than that which is disclosed herein, for providing this assistance. If the Company does not complete the acquisition of theMaven Network, Inc. as described elsewhere in its SEC filings, the Company does not have an estimate as to when it will complete a qualified merger, acquisition, or strategic, and there is no assurance that such opportunities will be available, or if available, upon favorable terms.  If the Company is unsuccessful in completing a suitable merger, acquisition or strategic alliance, then the Board of Directors may liquidate the Company and distribute all its remaining assets, which consist primarily of cash and available-for-sale securities, to its stockholders.

 

The Company believes that if it completes a suitable merger, acquisition or strategic alliance target, it will need additional capital to complete the transaction and continued funding of any acquired business. The Company, at this time, cannot estimate the amount of financing it may need for a transaction or acquired business. There is no assurance that it will be able to obtain any required funding for a transaction, or that if it is obtainable it will be on acceptable terms.

 

The Company anticipates that it will incur operating losses from operations in the next twelve months, until it enters into a suitable merger, acquisition or strategic alliance transaction, or until its liquidation.

 

Cash used in operating activities for the nine months ended September 30, 2016 was approximately $127,000, which primarily consisted of an operating loss of approximately $210,700, an increase in other current assets of approximately $12,900, an increase in accounts payable of approximately $59,400, and adjustments for non-cash expenses consisting of stock-based compensation of approximately $28,100, and a realized gain of approximately $2,900 on available for sale securities, and a change in the conversion feature liability of approximately $12,100 related to the Company’s Series G Convertible Preferred Stock.

 

Cash provided by investing activities for the nine months ended September 30, 2016 of approximately $60,400 was due to the maturity of available-for-sale securities, offset by an increase in notes receivable of $638,351.

 

Cash used in operating activities for the nine months ending September 30, 2015 was approximately $136,000, which primarily consisted of an operating loss of approximately $164,000, an increase in other current assets of approximately $9,800, decrease in accounts payable of approximately $8,500, and adjustments for non-cash expenses consisting of stock-based compensation of $37,500, and a realized gain of approximately $1,700 on available for sale securities, and a change in the conversion feature liability of approximately $11,000 related to the Company’s Series G Convertible Preferred Stock.

 

 15 

 

 

Cash used in investing activities for the nine months ended September 30, 2015 of approximately $65,000 was due to the purchase of available-for-sale securities of approximately $1,221,000, offset by the maturity or sale of available-for-sale securities of approximately $1,156,000.

 

Critical Accounting Policies and Estimates

 

There have been no significant changes during the nine months ended September 30, 2016 to the critical accounting policies disclosed in the Company’s annual financial statements in its Form 10-K for the year ended December 31, 2015.

 

Item 3.  Quantitative and Qualitative Disclosures about Market Risk

 

Market risk represents the risk of loss that may impact the Company’s financial position, operating results or cash flows due to changes in U.S. interest rates.  The Company’s exposure to market risk is confined to its available-for-sale investments, all of which it expects to hold less than one year. The goals of the Company’s cash investment policy are the security of the principal amount invested and fulfillment of liquidity needs.  The Company currently does not hedge interest rate exposure. Because of the short-term nature of its investments, the Company does not believe that an increase in market rates would have any material negative impact on the value of its investment portfolio.

 

As of September 30, 2016, the Company held approximately $479,000 in money market and checking accounts at two institutions.  The Company has a checking account at one institution with a balance of approximately $303,000 at September 30, 2016.  The funds in this account are fully insured by the Federal Deposit Insurance Corporation (“FDIC”) as of September 30, 2016. The Company has a money market account in a brokerage account with a second financial institution, invested in short-term federal securities, municipal bonds, and corporate bonds, with a money market cash balance of approximately $176,000 at September 30, 2016. Assets in this brokerage account are protected by the Securities Investor Protection Corporation (“SIPC”) up to $500,000 (with a limit of $250,000 for cash). Throughout the year the account balances at these institutions periodically exceed FDIC and SIPC insurance coverage; however, the company has not experienced losses in these accounts and believes it is not exposed to any significant credit risk.

 

Item 4.  Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time period specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the reports filed under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer. We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2016 (the “Evaluation Date”). Based upon the evaluation of our disclosure controls and procedures as of the Evaluation Date, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective because of the identification of a material weakness in our internal control over financial reporting which is identified below, which we view as an integral part of our disclosure controls and procedures.

 

 16 

 

 

Management’s Report on Internal Control Over Financial Reporting

 

Our management assessed the effectiveness of our internal control over financial reporting as of September 30, 2016. In making this assessment, it used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on its evaluation, our management concluded that there is a material weakness in our internal control over financial reporting and management has concluded that the Company’s internal controls over financial reporting are ineffective as of September 30, 2016. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Management believes that despite these weaknesses in internal controls, there are no material misstatements in our annual financial statements.

 

The material weakness relates to the lack of segregation of duties in our financial reporting process and our utilization of outside third party consultants. We do not have a separately designated audit committee. These weaknesses are due to our lack of additional accounting and operational staff. To remedy this material weakness, we ultimately, if and when we conclude a business combination, will engage an internal accounting staff to assist with financial reporting. We have no estimate as to when we will conclude a business combination so as to be able to remedy this and any other material weaknesses we have in our internal controls over financial reporting.

 

Changes in Internal Controls over Financial Reporting

 

There were no changes in our internal control over financial reporting during the three months ended September 30, 2016, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 17 

 

 

Part II. OTHER INFORMATION

 

Item 1.  Legal Proceedings

 

From time to time, the Company may be subject to other claims and litigation arising in the ordinary course of business.  The Company is not currently a party to any legal proceedings that it believes would reasonably be expected to have a material adverse effect on the Company’s business, financial condition or results of operations.

 

Item 1A.  Risk Factors

 

As of the date of this filing, there have been no material changes from the risk factors disclosed in Item 1A (Risk Factors) contained in our Form 10-K for the year ended December 31, 2015, filed with the SEC on March 30, 2016.  We operate in a changing environment that involves numerous known and unknown risks and uncertainties that could materially affect out operations.  The risks, uncertainties and other factors set forth in our Form 10-K for the year ended December 31, 2015, filed with the SEC on March 30, 2016, may cause our actual results, performances and achievements to be materially different from those expressed or implied by our forward-looking statements.  If any of these risks or events occurs, our business, financial condition or results of operations may be adversely affected.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

None.

 

Item 5.  Other Information

 

On August 11, 2016, the Company entered into a term note agreement (“Term Note”) with theMaven Network, Inc. (“Borrower”) for a loan of $150,000, plus expenses incurred by the Company in connection with the execution of this term note. The note is due at the earlier of (1) February 13, 2017, or (ii) the occurrence of certain events, as defined in the agreement. The note is secured by a personal guarantee of the principal officer of the Borrower (“Borrower Officer”). The $150,000 amount was guaranteed by MDB until the extension of the additional principal described below. The principal amount as of August 11, 2016, including expenses incurred by the Company, is $155,451. The Term Note provides that the principal amount of the loan would be increased by $350,000 (“Additional Amount”), plus expenses incurred by the Company in connection with the Term Note, if and when the Borrower Officer provides additional security for the total loan amount in the form of a mortgage on certain real estate (the “Mortgage”).  The Mortgage was provided in late August and the Company subsequently extended the Additional Amount to Borrower.  The interest rate on the borrowed amount is 8% per annum.  The loan agreement contains additional covenants, representations and events of default.

 

The Term Note was amended on August 25, 2016 to provide details of the Mortgage.  The Term Note was further amended on September 26, 2016 to extend an additional $125,000 to the Borrower.  This additional $125,000 of principle is guaranteed by MDB. As of September 30, 2016, the aggregated principal amount under the Term Note, including expenses incurred by the Company, is $638,351.

 

On October 14, 2016, the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with theMaven Network, Inc., a Nevada corporation (“theMaven”), and the shareholders of theMaven, holding all of the issued and outstanding shares of theMaven (collectively, “theMaven Shareholders”). The transaction will result in the Company acquiring theMaven as a wholly owned subsidiary by the exchange of all of the outstanding securities of theMaven held by theMaven Shareholders for a number of newly issued shares of the common stock of the Company, representing approximately 55% of the issued and outstanding shares immediately after the transaction (the “Share Exchange”). The final number of shares of common stock to be issued to theMaven Shareholders  will be determined and adjusted based on an exchange formula set forth in the Share Exchange Agreement.

 

 18 

 

 

The Share Exchange Agreement contains customary representations and warranties from theMaven, theMaven Shareholders and the Company. The closing is conditioned on certain pre-closing conditions, including but not limited to the preparation of the financial statements of theMaven, entry of employment agreements with the current, key employees of theMaven, the Company being current in its SEC reporting, the Company being able to file the Current Report on Form 8-K for the transaction on a timely basis and certain other covenants being satisfied. At the closing, 35% of the shares issued to theMaven Shareholders will be placed in escrow and will be subject to indemnification claims for breach of representations and warranties in the Share Exchange Agreement by theMaven and theMaven Shareholders, and subject to repurchase at $.01 per share by the Company if theMaven does not meet specific milestone achievements. The Company will be required to issue additional shares of its common stock in the event it breaches any of its representations and warranties, up to the number of shares placed in escrow by theMaven Shareholders. Upon the closing of the transaction, the Term Note will be cancelled and the Mortgage and the guarantees of the Term Note will be terminated.

 

The Company expects to close the Share Exchange in the next several weeks. The Share Exchange Agreement provides that the transaction must close prior to December 31, 2016.

 

Item 6.  Exhibits

 

Exhibit
No.
  Description
3.1   Articles of Incorporation (1)
3.2   By-laws (1)
10.1   Form of Promissory Note dated August 11, 2016, as amended *
10.2   Form of Guarantee by borrower representative and MDB Capital Group LLC *
10.3   Form of Share Exchange Agreement dated October 14, 2016, among Integrated Surgical Systems, Inc., theMaven Network, Inc. and the shareholders of theMaven Network, Inc.  (2)
31.1   Certification Pursuant to Exchange Act Rule 13a-14(a) of Christopher A. Marlett *
31.2   Certification Pursuant to Exchange Act Rule 13a-14(a) of Gary A. Schuman *
32.1   Certification Pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002 of Christopher A. Marlett  *
32.2   Certification Pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002 of Gary A. Schuman *
101.INS   XBRL Instance Document *
101.SCH   XBRL Taxonomy Extension Schema Document *
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document *
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document *
101.LAB   XBRL Taxonomy Extension Label Linkbase Document *
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document *

 

(1)Incorporated by reference to Form SB-2 filed on July 30, 1996 (file no. 333-09207)

 

(2)Incorporated by reference from Exhibition 10.1 of the Current Report on Form 8-K filed with the SEC on October 17, 2016.

 

*Filed herewith

 

 19 

 

 

SIGNATURES

 

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  INTEGRATED SURGICAL SYSTEMS, INC.
     
  By: /s/ Gary A. Schuman
    Gary A. Schuman, Chief Financial Officer
     
Dated: October 28, 2016    

 

 20 

 

EX-10.1 2 v451112_ex10-1.htm EXHIBIT 10.1

Exhibit 10.1

 

TERM LOAN NOTE

 

August 11, 2016

 

1.             Promise to Pay. For value received, _________, a Nevada corporation having its headquarters at ______ (the “Borrower”), promises to pay to Integrated Surgical Systems, Inc. (the “Holder”), with an office at 2425 Cedar Springs Rd, Dallas, TX 75201 (the “Payment Office”), in lawful money of the United States of America, the Loan Amount (herein defined), along with interest thereon at a rate per annum as set forth below and such other unpaid obligations owing from time to time hereunder (together the principal, interest and other obligations are referred to as the “Obligations”).

 

2.             (a)       Certain Defined Terms. The following terms as used in this promissory note (this “Note”) shall have the respective meanings set forth opposite such terms below, such meanings to be applicable equally to both the singular and plural forms of such terms:

 

Applicable Rate” means a rate per annum equal to 8%.

 

Borrower’ Business” means, a curated social media website business.

 

Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks in New York City are authorized or required to close.

 

Fundamental Change” shall mean any of the following: (i) termination of the Borrower’s Business, or (ii) either _______. ceases to actively be involved in the day to day activity of the Borrower’s Business.

 

Loan Amount” means the principal sum of One Hundred Fifty Thousand United States Dollars ($150,000.00) advanced upon execution of this Note, and an additional Three Hundred Fifty Thousand United States Dollars ($350,000.00) that shall be advanced by Holder only after ____ provides the mortgages in favor of the Holder as indicated in Section 6, plus the reasonable expenses of the Holder in creating this facility and obtaining the security interest of the mortgages, which will be added to the principle sum from time to time, as reflected on Schedule 1, and notified to the Borrower by the Holder.

 

Maturity Date” means the earlier of (i) February 13, 2017 (or such earlier date on which this Note and the indebtedness evidenced hereby shall become due and payable in accordance with its terms), and (ii) the occurrence of a Fundamental Change.

 

Person” means an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture, governmental authority or other entity of whatever nature.

 

 

 

 

(b)       Other Defined Terms. Other terms defined are in the other parts of this Note indicated below:

 

“Borrower” Section 1
“Event of Default” Section 8
“Holder” Section 1
“Loan Amount” Section 1
“Mortgage Documents” Section 6
“Note” Section 2(a)
“Obligations” Section 1
“Payment Office” Section 1

 

3.             Maturity Date. This Note shall mature on the Maturity Date.

 

4.             Scheduled Payments of Principal, Interest and Default Interest.

 

(a)       Borrower agrees to repay the outstanding principal amount evidenced by this Note on the Maturity Date.

 

(b)       The unpaid principal amount of this Note shall accrue interest, as of the date hereof, at the Applicable Rate, shall be payable on the Maturity Date, and shall be paid in cash.

 

(c)       Interest shall be calculated on the basis of a 360-day year based on the actual number of days during the period for which such interest is payable. If any payment on this Note becomes due and payable on a day that is not a Business Day, the due date thereof shall be extended to the next succeeding Business Day. Payments of principal and interest on this Note shall be made to Holder at the Payment Office. Upon repayment in full of the loans, interest and other Obligations evidenced by this Note, the Borrower may require Holder to surrender this Note.

 

(d)       Each payment made hereunder will be applied, first, to the payment of any indemnified costs payable under Section 10(d) of this Note, then to the payment of accrued and unpaid interest, and the balance, if any, to the unpaid principal balance of this Note and any other Obligations evidenced hereby.

 

(e)       To the extent permitted by law, upon the occurrence and during the continuance of an Event of Default, the principal amount of this Note shall bear interest from the date such Event of Default occurred until cured or waived, at the rate per annum equal to the Applicable Rate plus 5% per annum. Any interest accruing pursuant to this paragraph (e) shall be payable on demand.

 

5.             Prepayments. This Note may be prepaid in whole or in part, at any time or from time to time, without any penalty or premium, provided, that such prepayment shall be accompanied by accrued and unpaid interest on that portion of the Note being prepaid to the date of prepayment. Upon prepayment of part of the principal amount of this Note, the Borrower may require Holder to present this Note for notation on Schedule 2 hereto of such adjustment and payment.

 

 

 

  

6.             Collateral. The Obligations of Borrower under this Note shall be secured by a personal guarantee of _________, the President and the largest shareholder of the Borrower. The extension of the additional Loan Amount of $350,000 is subject to the provision of additional security of the Obligations through mortgages pursuant to mortgage documentation, reasonably acceptable to Holder, on the two condominiums owned by ____, located in Whistler, British Columbia, Canada (the “Mortgage Documents”). The guarantee of and the mortgages for the Obligations of the Borrower under this Note is being provided as an accommodation to Holder to extend the Loan Amount, which the Holder would not otherwise make to the Borrower.

 

7.             Covenants. The Borrower hereby covenants and agrees with the Holder that that so long as the Obligations (other than contingent indemnification obligations as to which no claim has been asserted) under this Note remain outstanding, that Borrower not shall, without the prior written consent of Holder, sell, assign, transfer, encumber or otherwise dispose of all or any portion of the Borrower’s rights, title and interest in the Borrower or in its Business, except for (a) disposal of damaged, obsolete or worn out equipment, in each case in the ordinary course of the Borrower’s Business, (b) the sale or licensing of other intellectual property of the Borrower on an arms-length basis and in the ordinary course of the Borrower’s Business, and (c) investment securities of or rights in the Borrower or its Business sold or issued by the Company to __________.

 

8.             Events of Default. It shall constitute an event of default (“Event of Default”) of this Note if any one or more of the following shall occur for any reason:

 

(a)       any failure to pay principal and interest on this Note pursuant to Section 3, Section 4 (including any default interest as prescribed by Section 4(e)) or Section 5 after the same shall become due (whether by scheduled maturity, acceleration, demand or otherwise); or

 

(b)       any representation or warranty made or deemed made by or on behalf of either Borrower under or in connection with this Note or in the Mortgage Documents shall have been incorrect in any respect when made or deemed made;

 

(c)       The Borrower shall fail to perform or observe any term, covenant (including without limitation, any covenant under Section 7 of this Note) or agreement contained in this Note or the Mortgage Documents;

 

(d)       The Borrower or _____ shall (i) become insolvent or shall fail generally to pay its debts as they mature or shall apply for, shall consent to, or shall acquiesce in the appointment of a custodian, trustee or receiver for itself or for a substantial part of his property or assets; or, in the absence of such application, consent or acquiescence, a custodian, trustee or receiver shall be appointed for any Borrower or for a substantial part of any Borrower’s property or assets, or any Borrower shall make an assignment for the benefit of creditors; or (ii) be the subject of any bankruptcy, reorganization, debt arrangement or other proceedings under any bankruptcy or insolvency act or law, state, federal or foreign, now or hereafter existing, whether voluntary or involuntary, which shall not have been dismissed within 60 days or an order for relief shall have been entered against such Borrower; or

 

 

 

 

(e)       Any Mortgage Document entered into in conjunction with the Loan shall at any time after its execution and delivery and for any reason cease: (1) to create a valid and perfected security interest in and to the property purported to be subject to such Mortgage Document with a priority as required by this Note; or (2) to be in full force and effect or shall be declared null and void, or the validity or enforceability thereof shall be contested by Borrower or ______, or Borrower or ___________, as applicable, shall deny it/he has any further liability or obligation under any Mortgage Document, or Borrower or ___ shall fail to perform any of Borrower’s or ____ obligations under any Mortgage Document;

 

(f)       The occurrence of any event that could reasonably be expected to have a material adverse effect on the Borrower or ________ in respect of any of the obligations of this Note or under the guarantee or Mortgage Documents and the security interest provided thereby.

 

9.             Remedies. Upon the occurrence and during the continuance of an Event of Default, Holder shall have the right to, without notice to or demand on the Borrower, to declare the outstanding principal and all accrued and unpaid interest hereunder immediately due and payable, provided, that, upon the occurrence of an Event of Default specified in Section 8(d), all amounts owing under this Note shall immediately become due and payable. In addition to the right of acceleration, upon the occurrence of an Event of Default, Holder shall have any and all of the rights and remedies available at law or in equity.

 

10.           Miscellaneous Provisions.

 

(a)       This Note may not be amended or modified, and revision hereto shall not be effective, except by an instrument in writing executed by the Borrower and Holder.

 

(b)       Any notice or communication by the Borrower, on the one hand, or Holder on the other hand, to the other is duly given if in writing and delivered in Person or mailed by first class mail (registered or certified, return receipt requested), or overnight air courier guaranteeing next day delivery, to the others’ address set forth in Section 1 to this Note. Holder or the Borrower, by notice to the other party, may designate additional or different addresses for subsequent notices or communications. All notices and communications shall be deemed to have been duly given: at the time delivered by hand, if personally delivered; three Business Days after being deposited in the mail, postage prepaid, if mailed; and the next Business Day after timely delivery to the courier, if sent by overnight air courier guaranteeing next day delivery.

 

(c)       Every provision of this Note is intended to be severable. In the event any term or provision hereof is declared by a court of competent jurisdiction to be illegal or invalid for any reason whatsoever, such illegality or invalidity shall not affect the balance of the terms and provisions hereof, which terms and provisions shall remain binding and enforceable.

 

(d)       The Borrower shall jointly and severally pay to Holder, on demand, all costs of administration, enforcement and collection (including without limitation, any fees, disbursements and other charges of primary and special counsel to Holder) of this Note, whether or not any action or proceeding is brought to enforce the provisions hereof.

 

(e)       No failure on the part of Holder to exercise, and no delay in exercising, any right, power, privilege or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof by Holder preclude any other or further exercise thereof or the exercise of any other right, power, privilege or remedy of Holder.

 

 

 

 

(f)       Headings at the beginning of each numbered Section of this Note are intended solely for convenience of reference and are not to be deemed or construed to be a part of this Note.

 

(g)       This Note may not be sold, transferred or otherwise hypothecated, in whole or in part by the Borrower. Any attempted sale, transfer or hypothecation of this Note in violation of this provision shall be null and void.

 

(h)       The obligations of the Borrower, including the Obligations, under this Note shall be automatically reinstated if and to the extent that for any reason any payment by or on behalf of the Borrower in respect of this Note is rescinded or must be otherwise restored by Holder, whether as a result of any proceedings in bankruptcy or reorganization or otherwise, and the Borrower agrees that it will indemnify Holder on demand for all reasonable costs and expenses (including, without limitation, reasonable fees of counsel) incurred by Holder in connection with any such rescission or restoration, including any such costs and expenses incurred in defending against any claim alleging that such payment constituted a preference, fraudulent transfer or similar payment under any bankruptcy, insolvency or similar law. The provisions of this paragraph (h) shall survive the termination of this Note.

 

(i)       This Note shall be governed and controlled as to validity, enforcement, interpretation, construction, effect and in all other respects, including, but not limited to, the legality of the interest charged hereunder, by the statutes, laws and decisions of the State of New York without giving effect to such State’s conflicts of laws principles.

 

The Borrower hereby irrevocably consents to the venue and jurisdiction of the federal and state courts located in New York with respect to any proceeding which may be brought in connection with the Note. The Borrower hereby expressly and irrevocably waives the right to a trial by jury in any action or proceeding arising out of this Note. The Borrower waives any and all rights under the laws of the State of New York to object to the jurisdiction of, or the commencement of any such claim, action or proceeding in, the State courts of the State of New York or the federal courts of the State of New York as hereinabove set forth.

 

 

 

[Remainder of page left intentionally blank]

 

 

 

 

IN WITNESS WHEREOF, the Borrower has executed this Note as of the date first set forth above.

 

 

  By:         
Name [Printed]:      
  Title:       

 

 

 

 

 

 

 

 

Schedule 1

 

 

Principle Amount Date of Extension of Credit Aggregate Principle Amount Due Notes
       
$150,000 August 11, 2016 $150,000 Loan extension
$3,500 August 11, 2016 $153,500 Expenses of first tranche – note, guarantee, corporate authorization
       
       

  

 

Schedule 2

 

Date of Payment Principal Paid or Prepaid Aggregate Principal Balance Notation Made By
       
       
       
       
       
       
       
       
       
       
       
       

 

 

EX-10.2 3 v451112_ex10-2.htm EXHIBIT 10.2

Exhibit 10.2

 

GUARANTEE

 

 

 

New York, New York Dated: ______ __, 2016

 

In order to induce Integrated Surgical Systems, Inc. (herein called “Maker”) to make the loan evidenced by the Promissory Note, executed by _______, a Nevada corporation (the “Obligor”) and dated as of an even date herewith (the “Note”) or grant other financial accommodations to or for the account of (or in reliance on the credit of) the Obligor, the undersigned, ____ an [individual/corporation and a United States citizen] with a business address at _______, irrevocably, absolutely and unconditionally guarantees to Maker the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of all obligations of Obligor now or hereafter existing under the Note, whether for principal, interest (including without limitation interest accruing after the filing of any petition in bankruptcy or suspension of payments or the commencement of any insolvency, reorganization, arrangement, adjustment or like proceeding, relating to Obligor, whether or not allowable as a claim), fees, expenses (including reasonable attorneys’ fees and expenses), indemnities or otherwise (such obligations being the “Guaranteed Obligations”). Without limiting the generality of the foregoing, the liability of the undersigned shall extend to all amounts that constitute part of the Guaranteed Obligations and would be owed by Obligor to the Maker under the Note but for the fact that they are unenforceable or not allowable due to the existence of a bankruptcy, reorganization or similar proceeding involving Obligor.

 

The undersigned guarantees that the Guaranteed Obligations will be paid strictly in accordance with the terms of the Note, regardless of any law, regulation or order now or hereafter in effect in any jurisdiction affecting any of such terms or the rights of the undersigned with respect thereto. The obligations of the undersigned hereunder are independent of the Guaranteed Obligations, and a separate action or actions may be brought and prosecuted against the undersigned to enforce this Agreement, irrespective of whether any action is brought against Obligor or whether Obligor is joined in any such action or actions. The liability of the undersigned under this Agreement shall be absolute and unconditional irrespective of, and the undersigned hereby irrevocably waives any right that it now or hereinafter may have to assert as a defense, any of the following: (i) any lack of validity or enforceability of the Note or any agreement or instrument relating thereto; (ii) any change in the time, manner or place of payment of, or in any other term of, all or any of the Guaranteed Obligations, or any other amendment or waiver of or any consent to departure from the Note; (iii) any taking, exchange, release or non-perfection of any collateral, or any taking, release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Guaranteed Obligations; (iv) any manner of application of collateral, or proceeds thereof, to all or any of the Guaranteed Obligations, or any manner of sale or other disposition of any collateral for all or any of the Guaranteed Obligations or any other assets of Obligor; (v) any change, restructuring or termination of the limited liability corporate existence of Obligor; or (vi) any other circumstance (including, without limitation, any statute of limitations) that might otherwise constitute a defense available to, or a discharge of, Obligor or the undersigned.

 

 

 

 

This guarantee shall continue to be effective or be reinstated, as the case may be, if at any time any payment of any of the Guaranteed Obligations is rescinded or must otherwise be returned by the undersigned upon the insolvency, bankruptcy or reorganization of Obligor or otherwise, all as though such payment had not been made.

 

The rights of the Maker hereunder shall not be conditioned or contingent upon the pursuit by the Maker of any right or remedy against the Obligor or against any other person which may be or become liable in respect of all or any part of the Guaranteed Obligations or against any collateral security therefor, guarantee therefor or right of offset with respect thereto. The Maker shall not be liable for any failure to demand, collect or realize upon all or any part of any collateral or for any delay in doing so, nor shall the Maker be under any obligation to sell or otherwise dispose of any collateral upon the request of the undersigned or any other person or to take any other action whatsoever with regard to any collateral or any part thereof.

 

The undersigned waives notice of acceptance of this guarantee and notice of any liability to which it may apply, and waives presentment, demand for payment, protest, notice of dishonor or nonpayment of any Guaranteed Obligations, or suit or taking other action by Maker against, and any other notice to, any party liable thereon (including the undersigned) and waives any defense, offset or counterclaim to any liability hereunder. Maker may at any time and from time to time (whether or not after revocation or termination of this guarantee) without the consent of, or notice to, the undersigned, without incurring responsibility to the undersigned, without impairing or releasing the obligations of the undersigned hereunder, upon or without any terms or conditions and in whole or in part: (1) change the manner, place or terms of payment, and/or change or extend the time of payment of, renew or alter, any Guaranteed Obligation, any security therefor, or any liability incurred directly or indirectly in respect thereof, and the guarantee herein made shall apply to the Guaranteed Obligations as so changed, extended, renewed or altered; (2) sell, exchange, release, surrender, realize upon or otherwise deal with in any manner and in any order any property by whomsoever at any time pledged or mortgaged to secure, or howsoever securing, the liabilities hereby guaranteed or any liabilities (including any of those hereunder or under any other guarantee of the Guaranteed Obligations) incurred directly or indirectly in respect thereof or hereof, and/or offset there against; (3) exercise or refrain from exercising any rights against the Obligor or others (including the undersigned or under any other guarantee of the Guaranteed Obligations) or otherwise act or refrain from acting; (4) settle or compromise any Guaranteed Obligation, any security therefor or any liability (including any of those hereunder or under any other guarantor of the Guaranteed Obligations) incurred directly or indirectly in respect thereof or hereof, and may subordinate the payment of all or any part thereof to the payment of any liability (whether due or not) of the Obligor to creditors of the Obligor other than Maker and the undersigned: and (5) apply any sums by whomsoever paid or howsoever realized to any Guaranteed Obligation to Maker regardless of what liability or liabilities of the Obligor remain unpaid.

 

No invalidity, irregularity or unenforceability of all or any part of the liabilities hereby guaranteed or of any security therefor or of any other guarantee of the Guaranteed Obligations shall affect, impair or be a defense to this guarantee. The liability of the undersigned hereunder is primary, absolute and unconditional and shall not be subject to any offset, defense or counterclaim of the Obligor. This guarantee is a continuing one and all liabilities to which it applies or may apply under the terms hereof shall be conclusively presumed to have been created in reliance hereon. This guarantee shall continue until the death of such undersigned or the discharge in full of the Guaranteed Obligations.

 

 

 

 

Upon the happening of any of the following events: (i) the death of the undersigned or the dissolution or insolvency of the Obligor, or (ii) suspension of business of the Obligor or of any other guarantor of the Guaranteed Obligations, or (iii) the issuance of any warrant of attachment against any of the property of the Obligor or of the undersigned or of any other guarantor of the Guaranteed Obligations, or (iv) the making by the Obligor or by the undersigned or by any other guarantor of the Guaranteed Obligations of any assignment for the benefit of creditors, or (v) a trustee, receiver or custodian being appointed for the Obligor or for the undersigned or for any other guarantor of the Guaranteed Obligations or for any property of any of them, or (vi) any proceeding being commenced by or against the Obligor or the undersigned or any other guarantor of the Guaranteed Obligations under any bankruptcy, reorganization, arrangement of debt, insolvency, readjustment of debt, receivership, liquidation or dissolution law or statute, in each of the foregoing cases, as applicable, Maker may, without notice to the Obligor or the undersigned or of any other guarantor of the Guaranteed Obligations, make the Guaranteed Obligations, whether or not then due, immediately due and payable hereunder as to the undersigned or of any other guarantor of the Guaranteed Obligations, and Maker shall be entitled to enforce the obligations of the undersigned hereunder. All sums of money at any time to the credit of the undersigned with Maker and any of the property of the undersigned at any time in the possession of Maker may be held by Maker as security for any and all obligations of the undersigned hereunder, notwithstanding that any of said money or property may have been deposited, pledged or delivered by the undersigned for any other, different or specific purpose. Any and all claims of any nature which the undersigned may now or hereafter have against the Obligor are hereby subordinated to the full payment to Maker of the Guaranteed Obligations and are hereby assigned to Maker as additional collateral security therefor.

 

In the event Maker takes any action, including retaining attorneys, for the purpose of effecting collection of the Guaranteed Obligations or of any liabilities of the undersigned hereunder, or protecting any of Maker's rights hereunder, the undersigned shall pay all reasonable costs and expenses of every kind for protection of the rights of Maker or for collection of the Guaranteed Obligations or such liabilities, including reasonable attorneys' fees.

 

If claim is ever made upon Maker for repayment or recovery of any amount or amounts received by Maker in payment or on account of any of the Guaranteed Obligations and Maker repays all or part of said amount to any party by reason of (a) any judgment, decree or order of any Court or administrative body having jurisdiction over Maker or any of its property, or (b) any settlement or compromise of any such claim effected by Maker with any such claimant (including the Obligor), then and in such event the undersigned agrees that any such judgment, decree, order, settlement or compromise shall be binding upon the undersigned, notwithstanding any prior revocation or release hereof or the prior cancellation of any note or other instrument evidencing any of the Guaranteed Obligations, or any prior release of any such liability of the Obligor, and the undersigned shall be and remain liable to Maker hereunder for the amount so repaid or recovered to the same extent as if such amount had never originally been received by Maker. The provisions of this paragraph shall survive, and continue in effect, notwithstanding any revocation or release hereof, unless such revocation or release shall specifically refer to this paragraph.

 

 

 

 

No delay on the part of Maker in exercising any of its options, powers or rights, or partial or single exercise thereof, shall constitute a waiver thereof. No waiver of any of its rights hereunder, and no modification or amendment of this guarantee, shall be deemed to be made by Maker unless the same shall be in writing, duly signed on behalf of Maker, and each such waiver, if any, shall apply only with respect to the specific instance involved, and shall in no way impair the rights of Maker or the obligations of the undersigned to Maker in any other respect or at any other time. The undersigned shall have no right (whether by contract or by operation of law) of subrogation, restitution, indemnification, reimbursement or any other or similar rights of a surety against the Obligor or any of its assets or property or any security held for any liabilities of the Obligor, and all such rights are hereby expressly waived. This guarantee and the rights and obligations of Maker and of the undersigned hereunder shall be governed and construed in accordance with the laws (other than the conflict of law rules) of the State of New York; and this guarantee is binding upon the undersigned, his, her, their or its executors, administrators, successors or assigns, and shall inure to the benefit of Maker, its successors or assigns. THE UNDERSIGNED AGREES AND DOES HEREBY WAIVE TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT AGAINST THE UNDERSIGNED ON ANY MATTERS WHATSOEVER ARISING OUT OF OR IN ANY WAY CONNECTED WITH THIS GUARANTEE, AND THE UNDERSIGNED HEREBY CONSENTS TO THE JURISDICTION OF THE SUPREME COURT OF THE STATE OF NEW YORK FOR A DETERMINATION OF ANY DISPUTE AS TO ANY SUCH MATTERS AND AUTHORIZES THE SERVICE OF PROCESS ON THE UNDERSIGNED BY REGISTERED MAIL SENT TO THE UNDERSIGNED AT THE ADDRESS OF THE UNDERSIGNED HEREINBELOW SET FORTH.

 

Any acknowledgement, new promise, payment of principal or interest or other act by the Obligor and others, with respect to the Guaranteed Obligations, shall be deemed to be made as agent of the undersigned for the purposes hereof, and shall, if the statute of limitations in favor of the undersigned against Maker shall have commenced to run, toll the running of such statute of limitations, and if such statute of limitations shall have expired, prevent the operation of such statute.

 

The undersigned shall be jointly and severally liable with the Obligor and any other guarantor of the Guaranteed Obligations. Notwithstanding that this guarantee may indicate that more than one Person (as defined in the Financing Agreement) is to execute this guarantee, any person signing this guarantee agrees to be bound hereby, whether or not any other Person signs this guarantee or any other guarantee of the Guaranteed Obligations at any time.

 

 

  X      

 

 

 

 

 

 

STATE OF   )  
    ) ss:
COUNTY OF     )  

 

 

On the ____ day of ________, 2016, before me, the undersigned, a Notary Public in and for the state of _________________, personally appeared, __________________, personally known to me or proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his capacity and that by his signature on the instrument, the individual or the person upon behalf of which the individual acted, executed the instrument.

 

 

_____________________________

 

 

 

 

 

EX-31.1 4 v451112_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Christopher A. Marlett, Chief Executive Officer of Integrated Surgical Systems, Inc., certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 of Integrated Surgical Systems, Inc. (the “registrant”);

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this  report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Quarterly Report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

 

(b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this Quarterly Report  our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Quarterly Report based on such evaluation; and

 

(d)   Disclosed in this Quarterly Report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the  registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: October 28, 2016 By:  /s/ Christopher A. Marlett  
    Christopher A. Marlett  
    Chief Executive Officer  

 

 

EX-31.2 5 v451112_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Gary A. Schuman, Chief Financial Officer of Integrated Surgical Systems, Inc., certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 of Integrated Surgical Systems, Inc. (the “registrant”);

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this  report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Quarterly Report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

 

(b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this Quarterly Report  our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Quarterly Report based on such evaluation; and

 

(d)   Disclosed in this Quarterly Report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the  registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

  

Dated: October 28, 2016 By:  /s/ Gary A. Schuman  
    Gary A. Schuman  
    Chief Financial Officer  

 

 

EX-32.1 6 v451112_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Christopher A. Marlett, Chief Executive Officer of Integrated Surgical Systems, Inc.  (the “Company”), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2016, which this certification accompanies (the “Periodic Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: October 28, 2016   /s/ Christopher A. Marlett  
    Christopher A. Marlett  
    Chief Executive Officer  

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. This written statement accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission, and will not be incorporated by reference into any filing of Integrated Surgical Systems, Inc. under the Securities Act of 1933 or the Securities Exchange Act of 1934, irrespective of any general incorporation language contained in such filing.

 

 

EX-32.2 7 v451112_ex32-2.htm EXHIBIT 32.2

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Gary A. Schuman, Chief Financial Officer of Integrated Surgical Systems, Inc.  (the “Company”), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2016, which this certification accompanies (the “Periodic Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: October 28, 2016   /s/ Gary A. Schuman  
    Gary A. Schuman  
    Chief Financial Officer  

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. This written statement accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission, and will not be incorporated by reference into any filing of Integrated Surgical Systems, Inc. under the Securities Act of 1933 or the Securities Exchange Act of 1934, irrespective of any general incorporation language contained in such filing.

 

 

 

EX-101.INS 8 issm-20160930.xml XBRL INSTANCE DOCUMENT 0000894871 2015-01-01 2015-09-30 0000894871 2016-01-01 2016-01-11 0000894871 2016-01-01 2016-09-30 0000894871 2016-04-01 2016-04-30 0000894871 2015-07-01 2015-09-30 0000894871 2016-07-01 2016-07-31 0000894871 2016-07-01 2016-09-30 0000894871 2016-08-11 0000894871 2016-09-30 0000894871 2016-10-21 0000894871 2015-12-31 0000894871 2014-12-31 0000894871 2015-09-30 0000894871 us-gaap:CommonStockMember 2015-12-31 0000894871 issm:CommonStockToBeIssuedMember 2015-12-31 0000894871 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0000894871 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0000894871 us-gaap:RetainedEarningsMember 2015-12-31 0000894871 us-gaap:CommonStockMember 2016-01-01 2016-09-30 0000894871 issm:CommonStockToBeIssuedMember 2016-01-01 2016-09-30 0000894871 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-09-30 0000894871 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-09-30 0000894871 us-gaap:RetainedEarningsMember 2016-01-01 2016-09-30 0000894871 us-gaap:CommonStockMember 2016-09-30 0000894871 issm:CommonStockToBeIssuedMember 2016-09-30 0000894871 us-gaap:AdditionalPaidInCapitalMember 2016-09-30 0000894871 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-09-30 0000894871 us-gaap:RetainedEarningsMember 2016-09-30 0000894871 us-gaap:MaximumMember 2016-09-30 0000894871 us-gaap:StockOptionMember 2016-01-01 2016-09-30 0000894871 us-gaap:StockOptionMember 2015-01-01 2015-09-30 0000894871 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2016-09-30 0000894871 us-gaap:MunicipalBondsMember 2016-09-30 0000894871 us-gaap:CertificatesOfDepositMember 2016-09-30 0000894871 us-gaap:CorporateDebtSecuritiesMember 2016-09-30 0000894871 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2015-12-31 0000894871 us-gaap:MunicipalBondsMember 2015-12-31 0000894871 us-gaap:CertificatesOfDepositMember 2015-12-31 0000894871 us-gaap:CorporateDebtSecuritiesMember 2015-12-31 0000894871 us-gaap:SeriesGPreferredStockMember 2016-09-30 0000894871 us-gaap:SeriesGPreferredStockMember 2015-12-31 0000894871 us-gaap:FairValueInputsLevel3Member 2016-01-01 2016-09-30 0000894871 issm:DirectorsTwoMember 2016-07-01 2016-09-30 0000894871 issm:DirectorsTwoMember 2016-01-01 2016-01-11 0000894871 issm:DirectorOneMember 2016-04-01 2016-04-30 0000894871 issm:DirectorsTwoMember 2016-04-01 2016-04-30 0000894871 issm:DirectorOneMember 2016-07-01 2016-07-31 0000894871 issm:DirectorsTwoMember 2016-07-01 2016-07-31 0000894871 issm:DirectorsTwoMember 2016-01-01 2016-09-30 0000894871 issm:MdbCapitalGroupLlcMember 2016-09-30 0000894871 issm:MdbCapitalGroupLlcMember 2015-12-31 0000894871 issm:MdbCapitalGroupLlcMember 2016-01-01 2016-09-30 0000894871 issm:RobertLevandeMember 2016-01-01 2016-09-30 0000894871 us-gaap:RedeemableConvertiblePreferredStockMember 2016-09-30 0000894871 us-gaap:RedeemableConvertiblePreferredStockMember 2015-12-31 0000894871 issm:ElevenAugustMember 2016-09-30 0000894871 issm:FourteenSeptemberMember 2016-09-30 0000894871 issm:TwentySixSeptemberMember 2016-09-30 0000894871 issm:ElevenAugustMember 2015-12-31 0000894871 issm:FourteenSeptemberMember 2015-12-31 0000894871 issm:TwentySixSeptemberMember 2015-12-31 0000894871 us-gaap:SubsequentEventMember 2016-10-14 0000894871 issm:TermNoteMember 2016-09-01 2016-09-26 0000894871 issm:TermNoteMember 2016-09-30 0000894871 issm:TermNoteMember 2016-08-11 0000894871 issm:TermNoteMember 2016-08-01 2016-08-11 0000894871 issm:MdbCapitalGroupLlcMember 2015-01-01 2015-09-30 0000894871 issm:MdbCapitalGroupLlcMember 2016-09-26 0000894871 issm:DirectorOneMember us-gaap:SubsequentEventMember 2016-10-01 2016-10-31 0000894871 issm:DirectorsTwoMember us-gaap:SubsequentEventMember 2016-10-01 2016-10-31 0000894871 us-gaap:SubsequentEventMember 2016-10-01 2016-10-31 0000894871 us-gaap:SeriesGPreferredStockMember 2016-01-01 2016-09-30 0000894871 us-gaap:StockOptionMember 2016-07-01 2016-09-30 0000894871 us-gaap:StockOptionMember 2015-07-01 2015-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 10-Q false 2016-09-30 2016 Q3 INTEGRATED SURGICAL SYSTEMS INC 0000894871 --12-31 Smaller Reporting Company ISSM 9530379 479187 545705 1097470 1776185 42846 29928 2257854 2351818 2257854 2351818 68984 9631 88395 76343 157379 85974 168496 168496 94835 92829 9375 12500 64543421 64514177 -62738143 -62527454 22491 5296 1931979 2097348 2257854 2351818 220900 179694 -220900 -179694 20188 25710 -12052 -11001 2875 1734 11011 16443 -209889 -163251 800 800 -210689 -164051 20070 -2883 -0.02 -0.02 -0.02 -0.02 9416859 9107461 9416859 9107461 2875 1879 -4762 17195 102009 49640 -102009 -49640 10637 7765 -2858 -10463 68 217 7847 -2481 -94162 -52121 4036 -3370 -90194 -55708 -0.01 -0.01 -0.01 -0.01 9476497 9190589 9476497 9190589 68 217 -3587 3968 28125 37500 12918 9792 59353 -8474 -126952 -135550 0 1221185 698785 1146754 60434 -65231 -66518 -200781 542215 341434 17195 -4762 92829 12500 64514177 5296 -62527454 9282981 83334 18750 2006 -12500 29244 0 0 200522 -83334 9375 0 9375 0 0 0 0 46876 0 0 0 0 -210689 0 0 17195 0 94835 9375 64543421 22491 -62738143 9483503 46876 -193494 0 0 17195 -210689 303000 250000 176000 500000 250000 1101281 1321537 175000 200000 4898 311517 741769 16795 4951 312863 762645 17011 4830 492237 1256649 17173 4885 492046 1261966 17288 739361 164331 171287 757136 165934 174400 1000000 1101281 1000 168496 1000 1321537 0.0059 0.777 0 P1Y 12052 9375 2016-01-11 83334 0.15 12500 41667 39063 19531 58594 0.16 9375 25000 39063 19531 58594 9375 0.16 28125 1097470 4951 1092519 1776185 4885 1771300 3000 27000 9375 638351 0 0.01 0.01 1000000 1000000 168 168 168 168 168496 168496 0.01 0.01 100000000 100000000 9483503 9483503 9282981 9282981 638351 0 0 9200 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>1. Organization and Operations</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Integrated Surgical Systems, Inc. (the &#8220;Company&#8221;) was incorporated in Delaware in 1990 to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures.&#160;&#160;On June 28, 2007, the Company completed the sale of substantially all of its operating assets.&#160;&#160;After completion of the sale, the Company no longer engaged in any business activities related to its former business, described above. The Company&#8217;s current operations are limited to completing a business combination or strategic alliance.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of September 20, 2016, the Company signed a letter of intent to pursue the acquisition of theMaven Network, Inc. and on October 14, 2016, it signed a share exchange agreement with theMaven Network, Inc. and its shareholders to acquire the company as a wholly owned subsidiary. The closing is expected to take place within a few weeks, but before December 31, 2016.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">If the Company does not complete the above mentioned acquisition of theMaven Network, Inc., then the Company does not have an estimate as to when it will complete a qualified merger, acquisition, or strategic alliance. There is no assurance that such opportunities will be available, or if available, upon favorable terms. If the Company is unsuccessful in completing a suitable merger, acquisition or strategic alliance, then the Board of Directors may liquidate the Company and distribute all its remaining assets, which consist primarily of cash and available-for-sale securities, to its stockholders.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company believes that if it identifies and completes a suitable merger, acquisition or strategic alliance target, it may need additional capital to complete the transaction or fund the continuing acquired operations. The Company, at this time, cannot estimate the amount of financing it may need for a transaction. There is no assurance that it will be able to obtain any required funding for a transaction, or that if it is obtainable it will be on acceptable terms.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>2. Significant Accounting Policies</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Basis of Presentation</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying unaudited condensed financial statements and related notes have been prepared in accordance with the rules and regulations under Regulation S-X of the Securities and Exchange Commission for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed balance sheet at December 31, 2015 has been derived from the Company&#8217;s audited financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to present fairly the financial position as of September 30, 2016, the results of operations and cash flows for the nine months then ended have been included. These condensed financial statements should be read in conjunction with the financial statements of the Company and the Company&#8217;s management discussion and analysis included in the Company&#8217;s Form 10-K for the year ended December 31, 2015. Interim results are not necessarily indicative of the results for a full year.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Use of Estimates</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.&#160;&#160;Actual results could materially differ from those estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Cash and Cash Equivalents</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Cash and cash equivalents include checking and money market accounts held in two financial institutions. The Company has a checking account at one institution with a balance of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">303,000</font> at September 30, 2016. The funds in this account are fully guaranteed by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. The Company has a brokerage account with a second financial institution, with a cash balance of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">176,000</font> at September 30, 2016. Assets in this brokerage account are protected by the Securities Investor Protection Corporation (&#8220;SIPC&#8221;) up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">500,000</font> (with a limit of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font> for cash).&#160;&#160; Throughout the year, the account balances at these institutions periodically exceed FDIC and SIPC insurance coverage; however, the Company has not experienced losses in these accounts and believes it is not exposed to any significant credit risk.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Stock-Based Compensation</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>&#160;</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Compensation costs for stock, warrants or options issued to employees and non-employees are based on the fair value method and accounted for in accordance with FASB ASC 718, &#8221; Compensation &#150; Stock Compensation.&#8221;&#160;&#160;The value of warrants and options are calculated using a Black-Scholes Model, using the market price of the Company&#8217;s common stock on the date of issuance for the employee options or warrants and the date of commitment for non-employee options or warrants, an expected dividend yield of zero, the expected life of the warrants or options and the expected volatility of the Company&#8217;s common stock.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Investments in Available-for-Sale Securities</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has a portfolio of investments in available-for-sale debt securities, which consist of fixed income debt securities, and which are accounted for in accordance with FASB ASC 320, &#8220;Investments - Debt and Equity Securities.&#8221;&#160;&#160;Management determines the appropriate classification of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date.&#160;&#160;Available-for-sale securities are stated at fair value, and unrealized holding gains and losses, net of the related deferred tax effect, if any, are reported as other comprehensive income, a separate component of stockholders&#8217; equity.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>&#160;</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Fair Value Measurement</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">FASB ASC 820 <i>&#8220;Fair Value Measurements and Disclosures&#8221;</i> clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, FASB ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"><font style="FONT-SIZE: 10pt">&#183;</font></td> <td style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt">Level 1 - Observable inputs that reflect quoted prices (unadjusted)&#160;for identical assets or liabilities in active markets.</font></td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"><font style="FONT-SIZE: 10pt">&#183;</font></td> <td style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt">Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.</font></td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"><font style="FONT-SIZE: 10pt">&#183;</font></td> <td style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt">Level 3 - Unobservable inputs which are supported by little or no market activity.</font></td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In accordance with FASB ASC 820, the Company measures its cash equivalents, investments in available-for-sale securities, and derivative liability at fair value. The company classifies its cash equivalents and investments in available for sale securities within Level 1 or Level 2 in the fair value hierarchy because the company uses quoted market prices or alternative pricing sources and models utilizing observable market inputs to determine their fair value. The Company&#8217;s derivative liability is classified within Level 3.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The carrying value of other current assets and liabilities are considered to be representative of their respective fair values because of the short-term nature of those instruments.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Income Taxes</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Deferred income taxes have been provided for temporary differences between financial statement and income tax reporting under the liability method, using expected tax rates and laws that are expected to be in effect when the differences are expected to reverse.&#160;&#160;A valuation allowance is provided when realization is not considered more likely than not.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company applies the provisions of FASB ASC 740, &#8220;<i>Income Taxes</i>.&#8221;&#160;&#160;ASC 740 clarifies the accounting for uncertainty in income taxes recognized in the Company&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s policy is to classify expenses as a result of income tax assessments as interest expense for interest charges and as penalties in general and administrative expenses for penalty assessments.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Recently Issued Accounting Pronouncements</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Basis of Presentation</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying unaudited condensed financial statements and related notes have been prepared in accordance with the rules and regulations under Regulation S-X of the Securities and Exchange Commission for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed balance sheet at December 31, 2015 has been derived from the Company&#8217;s audited financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to present fairly the financial position as of September 30, 2016, the results of operations and cash flows for the nine months then ended have been included. These condensed financial statements should be read in conjunction with the financial statements of the Company and the Company&#8217;s management discussion and analysis included in the Company&#8217;s Form 10-K for the year ended December 31, 2015. Interim results are not necessarily indicative of the results for a full year.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Use of Estimates</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.&#160;&#160;Actual results could materially differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Cash and Cash Equivalents</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Cash and cash equivalents include checking and money market accounts held in two financial institutions. The Company has a checking account at one institution with a balance of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">303,000</font> at September 30, 2016. The funds in this account are fully guaranteed by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. The Company has a brokerage account with a second financial institution, with a cash balance of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">176,000</font> at September 30, 2016. Assets in this brokerage account are protected by the Securities Investor Protection Corporation (&#8220;SIPC&#8221;) up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">500,000</font> (with a limit of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font> for cash).&#160;&#160; Throughout the year, the account balances at these institutions periodically exceed FDIC and SIPC insurance coverage; however, the Company has not experienced losses in these accounts and believes it is not exposed to any significant credit risk.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Stock-Based Compensation</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>&#160;</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Compensation costs for stock, warrants or options issued to employees and non-employees are based on the fair value method and accounted for in accordance with FASB ASC 718, &#8221; Compensation &#150; Stock Compensation.&#8221;&#160;&#160;The value of warrants and options are calculated using a Black-Scholes Model, using the market price of the Company&#8217;s common stock on the date of issuance for the employee options or warrants and the date of commitment for non-employee options or warrants, an expected dividend yield of zero, the expected life of the warrants or options and the expected volatility of the Company&#8217;s common stock.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Investments in Available-for-Sale Securities</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has a portfolio of investments in available-for-sale debt securities, which consist of fixed income debt securities, and which are accounted for in accordance with FASB ASC 320, &#8220;Investments - Debt and Equity Securities.&#8221;&#160;&#160;Management determines the appropriate classification of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date.&#160;&#160;Available-for-sale securities are stated at fair value, and unrealized holding gains and losses, net of the related deferred tax effect, if any, are reported as other comprehensive income, a separate component of stockholders&#8217; equity.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Fair Value Measurement</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">FASB ASC 820 <i>&#8220;Fair Value Measurements and Disclosures&#8221;</i> clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, FASB ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"><font style="FONT-SIZE: 10pt">&#183;</font></td> <td style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt">Level 1 - Observable inputs that reflect quoted prices (unadjusted)&#160;for identical assets or liabilities in active markets.</font></td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"><font style="FONT-SIZE: 10pt">&#183;</font></td> <td style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt">Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.</font></td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"><font style="FONT-SIZE: 10pt">&#183;</font></td> <td style="TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt">Level 3 - Unobservable inputs which are supported by little or no market activity.</font></td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In accordance with FASB ASC 820, the Company measures its cash equivalents, investments in available-for-sale securities, and derivative liability at fair value. The company classifies its cash equivalents and investments in available for sale securities within Level 1 or Level 2 in the fair value hierarchy because the company uses quoted market prices or alternative pricing sources and models utilizing observable market inputs to determine their fair value. The Company&#8217;s derivative liability is classified within Level 3.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The carrying value of other current assets and liabilities are considered to be representative of their respective fair values because of the short-term nature of those instruments.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Income Taxes</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Deferred income taxes have been provided for temporary differences between financial statement and income tax reporting under the liability method, using expected tax rates and laws that are expected to be in effect when the differences are expected to reverse.&#160;&#160;A valuation allowance is provided when realization is not considered more likely than not.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company applies the provisions of FASB ASC 740, &#8220;<i>Income Taxes</i>.&#8221;&#160;&#160;ASC 740 clarifies the accounting for uncertainty in income taxes recognized in the Company&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s policy is to classify expenses as a result of income tax assessments as interest expense for interest charges and as penalties in general and administrative expenses for penalty assessments.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Recently Issued Accounting Pronouncements</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>3.&#160;&#160;Income (Loss) Per Share</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period plus dilutive common stock equivalents, using the treasury stock method.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Common stock equivalents for convertible preferred stock of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,101,281</font></font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,321,537</font></font> shares were excluded from the calculation of loss per share for the nine months and three months ended September 30, 2016 and 2015, respectively, because they were not dilutive; these shares would have been dilutive if the Company had not had a net loss for the these periods.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Stock options for the purchase of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 175,000</font></font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 200,000</font></font> shares of the Company&#8217;s common stock were excluded from the calculation of income per share for the nine months and three months ended September 30, 2016 and 2015, respectively, because they were anti-dilutive.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>4.&#160;&#160;Notes Receivable</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has the following notes receivable:</div> &#160; <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Issue Date</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>September&#160;30,&#160;2016<br/> (Unaudited)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="51%"> <div>August 11, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>155,451</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>September 14, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>357,900</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>September 26, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>125,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>638,351</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On August 11, 2016, the Company entered into a term note agreement (&#8220;Term Note&#8221;) with&#160;theMaven Network, Inc.&#160;(&#8220;Borrower&#8221;) for a loan of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">150,000</font>, plus expenses incurred by the Company in connection with the execution of this term note. The note is due at the earlier of (1) February 13, 2017, or (ii) the occurrence of certain events, as defined in the agreement. The note is secured by a personal guarantee of the principal officer of the Borrower (&#8220;Borrower Officer&#8221;). The $150,000 amount was guaranteed by MDB until the extension of additional principal as described below. The principal amount as of August 11, 2016, including expenses incurred by the Company, is $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">155,451</font>. The&#160;Term Note provides that the principal amount of the loan would be increased by $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">350,000</font> (&#8220;Additional Amount&#8221;), plus expenses incurred by the Company in connection with the Term Note, if and when the Borrower Officer provides additional security for the total loan amount in the form of a mortgage on certain real estate (the &#8220;Mortgage&#8221;).&#160; The Mortgage was provided in late August and the Company subsequently extended the Additional Amount to Borrower.&#160; The interest rate on the borrowed amount is <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8</font>% per annum.&#160; The loan agreement contains additional covenants, representations and events of default.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Term Note was amended on August 25, 2016 to provide details of the Mortgage. &#160;The Term Note was further amended on September 26, 2016 to extend an additional $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">125,000</font> to the Borrower.&#160; This additional $125,000 of principle is guaranteed by MDB. As of September 30, 2016, the aggregated principal amount under the Term Note, including expenses incurred by the Company, is $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">638,351</font>.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has the following notes receivable:</div> &#160; <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Issue Date</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>September&#160;30,&#160;2016<br/> (Unaudited)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,&#160;2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="51%"> <div>August 11, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>155,451</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>September 14, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>357,900</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>September 26, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>125,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>638,351</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 155451 357900 125000 0 0 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>10.&#160;&#160;Subsequent Events</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On October 14, 2016, the Company entered into a share exchange agreement under which the company will acquire theMaven Network, Inc. (&#8220;Maven&#8221;) in an exchange of shares, whereby Maven will become a wholly owned subsidiary of the Company.&#160; The number of shares of the Company to be issued for the equity of Maven will be determined by a formula, and it is anticipated that the Company will issue approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 55</font>% of its issued and outstanding common stock immediately after the transaction.&#160; At the closing, it is agreed that one of Maven&#8217;s directors will become a director of the Company and several of their officers will also become officers of the Company under their current employment arrangements. The consummation of the acquisition is subject to various conditions precedent, as defined in the agreement, for each of the parties to the agreement. The Company anticipates the closing taking place within a few weeks.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.55 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>8.&#160;&#160;Related Party Transactions</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company entered into an Investment Banking Advisory Services agreement in November 2007 with MDB Capital Group LLC (&#8220;MDB&#8221;), and the parties extended this agreement indefinitely in April 2009.&#160;&#160;The agreement may be terminated by either party upon 30-days written notice.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has a securities investment account with MDB, consisting of (a) available-for-sale investments totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,097,470</font>, that include short-term federal securities of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,951</font>, and certificates of deposit, municipal securities and corporate debt securities totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,092,519</font> at September 30, 2016 (unaudited), and (b) available-for-sale investments totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,776,185</font>, that include short-term federal securities of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,885</font>, certificates of deposit, municipal securities and corporate debt securities totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,771,300</font> at December 31, 2015.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Mr. Christopher Marlett, the Chief Executive Officer and director of the Company, is also the Chief Executive Officer of MDB. Mr. Gary Schuman, who is the Chief Financial Officer of the Company, is also the Chief Financial Officer and Chief Compliance Officer of MDB.&#160;&#160;The Company compensates for Mr. Schuman&#8217;s services in the amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,000</font> per month, totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">27,000</font></font> for the nine months ended September 30, 2016 and 2015 (unaudited).&#160;&#160;Mr. Robert Levande, who is an officer and director of the Company, is also a senior managing director of MDB. In addition to shares of common stock (as discussed in Note 6), Mr. Levande was compensated $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,375</font> for his services as director for the nine months ended September 30, 2016 (unaudited).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">MDB has guaranteed $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">125,000</font> of the principle amount due on the Term Note from theMaven Network, Inc. described in Note 4 above. This guarantee will terminate upon the completion of the acquisition of theMaven Network, Inc. which is described in Note 1 above and Note 10 below.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 150000 125000 638351 155451 350000 0.08 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>5.&#160;&#160;Investment in Available-for-Sale Securities</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following is a summary of the Company&#8217;s investments in available-for-sale securities as of September 30, 2016 (unaudited):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Cost</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Unrealized<br/> Gains</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Unrealized<br/> Losses</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Fair&#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>U.S. federal agency securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,898</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>53</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,951</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Municipal securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>311,517</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,582</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(236)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>312,863</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Certificates of deposit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>741,769</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>31,612</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(10,736)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>762,645</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Corporate debt securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>16,795</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>216</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>17,011</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,074,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>33,463</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>(10,972)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,097,470</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 1.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following is a summary of the Company&#8217;s investments in available-for-sale securities as of December 31, 2015:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Cost</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Unrealized<br/> Gains</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Unrealized<br/> Losses</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Fair&#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>U.S. federal agency securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,830</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>55</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,885</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Municipal securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>492,237</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>789</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(980)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>492,046</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Certificates of deposit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,256,649</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>20,182</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(14,865)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,261,966</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Corporate debt securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>17,173</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>115</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>17,288</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,770,889</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>21,141</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>(15,845)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,776,185</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The cost and fair value of investments in fixed income available-for-sale debt securities, by contractual maturity, as of September 30, 2016 (unaudited), are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Cost</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Fair<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Due within one year</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>739,361</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>757,136</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Due after one year through three years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>164,331</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>165,934</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Due after three years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>171,287</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>174,400</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,074,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,097,470</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Expected maturities will differ from contractual maturities because the issuers of certain debt securities have the right to call or prepay their obligations without any penalties.&#160;&#160;The Company has classified the entire fair value of its investments in available-for-sale debt securities as current assets in the accompanying condensed balance sheets.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 27000 125000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong><strong>7.&#160;&#160;Stock-based compensation</strong></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For the nine months ended September 30, 2016, the Company had no activity related to stock options. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>As of September 30, 2016, a summary of options outstanding under the Company&#8217;s 2014 options grant was as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>Range&#160;of<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>Weighted-<br/> Average&#160;Remaining<br/> Contractual&#160;Life&#160;(Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Number<br/> Outstanding</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>Weighted-<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>Number<br/> Exercisable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Weighted-<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>0.17</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>2.63</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>175,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>0.17</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>175,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>0.17</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company agreed to compensate each director in the amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">25,000</font> per year, payable quarterly, beginning on January 1, 2016. Such compensation may be paid to each director either in the form of cash, or the Company&#8217;s common stock or a combination thereof at the election of such director which may be changed during the year with respect to future payments. The Company compensated one of its directors by issuing common stock, one of its directors by issuing common stock and in cash, and the third director in cash for services rendered in 2016. The Company compensated two of its four directors by issuing common stock, and two directors in cash for services rendered in 2015. The number of shares issued to each director was determined based upon the equivalent cash compensation accrued divided by the closing price of the Company&#8217;s common stock on the date that the compensation is fully earned each quarter, which is the last day of such quarter. The Company recorded stock-based compensation expense of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,375</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">28,125</font> for the three and nine months ended September 30, 2016 for two directors, which was recorded as common stock to be issued.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">January 11, 2016</font>, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 41,667</font> shares of common stock to each of two directors as compensation for the three months ended December 31, 2015. These shares, totaling <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 83,334</font>, were valued at a per share price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.15</font>, or a total of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">12,500</font>.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On April 12, 2016, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 39,063</font> shares of common stock to one director, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 19,531</font> shares of common stock to a second director as compensation for the three months ended March 31, 2016. These shares, totaling <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 58,594</font>, were valued at a per share price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.16</font>, or a total of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,375</font> (unaudited).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On July 11, 2016, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 39,063</font> shares of common stock to one director, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 19,531</font> shares of common stock to a second director as compensation for the three months ended June 30, 2016. These shares, totaling <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 58,594</font>, were valued at a per share price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.16</font>, or a total of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,375</font> (unaudited).</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On October 4, 2016, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 31,251</font> shares of common stock to one director, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15,625</font> shares of common stock to a second director as compensation for the three months ended September 30, 2016. These shares, totaling <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 46,876</font>, were valued at a per share price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.20</font>, or a total of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,375</font> (unaudited).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of September 30, 2016, a summary of options outstanding under the Company&#8217;s 2014 options grant was as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>Range&#160;of<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>Weighted-<br/> Average&#160;Remaining<br/> Contractual&#160;Life&#160;(Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Number<br/> Outstanding</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>Weighted-<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>Number<br/> Exercisable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Weighted-<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>0.17</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>2.63</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>175,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>0.17</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>175,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>0.17</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.17 P2Y7M17D 175000 0.17 175000 0.17 31251 15625 46876 0.20 9375 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>6.&#160;&#160;Redeemable Convertible Preferred Stock and Conversion Feature Liability</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s Certificate of Incorporation authorized <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,000,000</font> shares of undesignated, serial preferred stock. Preferred stock may be issued from time to time in one or more series. The Board of Directors is authorized to determine the rights, preferences, privileges, and restrictions granted to and imposed upon any wholly unissued series of preferred stock and designation of any such series without any further vote or action by the Company&#8217;s stockholders.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of September 30, 2016 and December 31, 2015, the Company&#8217;s only outstanding series of convertible preferred stock is the Series G Convertible Preferred Stock (&#8220;Series G&#8221;).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Series G stock has a stated value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,000</font> per share, and is convertible into common stock at a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> conversion price equal to 85% of the lowest sale price of the common stock on its listed market over the five trading days preceding the date of conversion (&#8220;Beneficial Conversion Feature&#8221;), subject to a maximum conversion price.</font> The number of shares of common stock that may be converted is determined by dividing the stated value of the number of shares of Series G to be converted by the conversion price. The Company may elect to pay the Series G holder in cash at the current market price multiplied by the number of shares of common stock issuable upon conversion.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For the nine months ended September 30, 2016 and the year ended December 31, 2015, no shares of Series G were converted into shares of common stock.&#160;&#160;At September 30, 2016 and December 31, 2015, the outstanding Series G shares were convertible into a minimum of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,101,281</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,321,537</font> shares of common stock, respectively.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Upon a change in control, sale of or similar transaction, as defined in the Certificate of Designation for the Series G, each holder of the Series G has the option to deem such transaction as a liquidation and may redeem his or her shares at the liquidation value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,000</font>, per share, for an aggregate amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">168,496</font>.&#160;&#160;The sale of all the assets on June 28, 2007 triggered the preferred stockholders&#8217; redemption option.&#160;&#160;As such redemption is not in the control of the Company, the Series G stock has been accounted for as if it was redeemable preferred stock and is classified on the balance sheet between liabilities and stockholders&#8217; equity.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The conversion feature of the preferred stock is considered a derivative according to ASC 815 &#8220;Derivatives and Hedging&#8221;, therefore, the fair value of the derivative is reflected in the financial statements as a liability, which was determined to be $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">88,395</font> as of September 30, 2016 (unaudited), and has been included as &#8220;conversion feature liability&#8221; on the accompanying condensed balance sheets. As of December 31, 2015, the fair value of the derivative was determined to be $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">76,343</font>.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The fair value of the conversion feature liability is calculated under a Black-Scholes Model, using the market price of the Company&#8217;s common stock on each of the balance sheet dates presented, the expected dividend yield, the expected life of the redemption and the expected volatility of the Company&#8217;s common stock.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment and considering factors specific to the conversion feature liability. Since some of the assumptions used by the Company are unobservable, the conversion feature liability is classified within the level 3 hierarchy in the fair value measurement.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The expected volatility of the conversion feature liability was based on the historical volatility of the Company&#8217;s common stock. The expected life assumption was based on the expected remaining life of the underlying preferred stock redemption. The risk-free interest rate for the expected term of the conversion feature liability was based on the average market rate on U.S. treasury securities in effect during the applicable quarter. The dividend yield reflected historical experience as well as future expectations over the expected term of the underlying preferred stock redemption. Therefore, the fair value of the conversion feature liability is sensitive to changes in above assumptions and changes of the Company&#8217;s common stock price.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The table below shows the quantitative information about the significant unobservable inputs used in the fair value measurement of level 3 conversion feature liability:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>September&#160;30,&#160;2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>(unaudited)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Expected remaining life of the redemption in years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>1.0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Risk free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>0.59</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Expected annual volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>77.70</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Annual rate of dividends</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The changes in the fair value of the derivative are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Balance as of January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>76,343</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Decrease of fair value</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>12,052</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Ending balance as of September 30, 2016 (unaudited)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>88,395</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following is a summary of the Company&#8217;s investments in available-for-sale securities as of September 30, 2016 (unaudited):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Cost</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Unrealized<br/> Gains</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Unrealized<br/> Losses</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Fair&#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>U.S. federal agency securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,898</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>53</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,951</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Municipal securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>311,517</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,582</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(236)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>312,863</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Certificates of deposit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>741,769</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>31,612</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(10,736)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>762,645</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Corporate debt securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>16,795</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>216</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>17,011</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,074,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>33,463</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>(10,972)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,097,470</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 1.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following is a summary of the Company&#8217;s investments in available-for-sale securities as of December 31, 2015:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Cost</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Unrealized<br/> Gains</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Unrealized<br/> Losses</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Fair&#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>U.S. federal agency securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,830</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>55</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,885</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Municipal securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>492,237</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>789</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(980)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>492,046</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Certificates of deposit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,256,649</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>20,182</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(14,865)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,261,966</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Corporate debt securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>17,173</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>115</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>17,288</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,770,889</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>21,141</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>(15,845)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,776,185</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The cost and fair value of investments in fixed income available-for-sale debt securities, by contractual maturity, as of September 30, 2016 (unaudited), are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Cost</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Fair<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Due within one year</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>739,361</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>757,136</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Due after one year through three years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>164,331</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>165,934</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Due after three years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>171,287</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>174,400</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,074,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,097,470</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The table below shows the quantitative information about the significant unobservable inputs used in the fair value measurement of level 3 conversion feature liability:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>September&#160;30,&#160;2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="16%" colspan="2"> <div>(unaudited)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Expected remaining life of the redemption in years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>1.0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Risk free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>0.59</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Expected annual volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>77.70</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Annual rate of dividends</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The changes in the fair value of the derivative are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Balance as of January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>76,343</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Decrease of fair value</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>12,052</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Ending balance as of September 30, 2016 (unaudited)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>88,395</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 1074979 1097470 1770889 1776185 1074979 conversion price equal to 85% of the lowest sale price of the common stock on its listed market over the five trading days preceding the date of conversion (Beneficial Conversion Feature), subject to a maximum conversion price. -193494 -168813 1101281 1321537 175000 200000 10972 0 236 10736 0 33463 53 1582 31612 216 15845 0 980 14865 0 21141 55 789 20182 115 0 0 44000 0.18 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>9.&#160;&#160;Commitments and Contingencies</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">From time to time, the Company may be subject to other claims and litigation arising in the ordinary course of business.&#160;&#160;The Company is not currently a party to any legal proceedings that it believes would reasonably be expected to have a material adverse effect on the Company&#8217;s business, financial condition or results of operations.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company may have a liability for additional state franchise taxes payable in the amount of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">44,000</font>, plus interest at <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 18</font>% per annum, for the years 2008-2014. Because of state statutory provisions, the underpaid amount will only be due once assessed and demanded by the state.&#160; The tax liability and associated interest has not been included as an accrued liability because management has determined that the likelihood of the state making the assessment is low.&#160; Depending on circumstances, management may change its estimate of the probability of an assessment and establish either an accrual or record a payment for the tax liability if assessed.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> EX-101.SCH 9 issm-20160930.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 103 - Statement - Condensed Balance Sheets [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - Condensed Statements of Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 105 - Statement - Condensed Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 106 - Statement - Condensed Statement of Changes in Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - Organization and Operations link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Income (Loss) Per Share link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Notes Receivable link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Investment in Available-for-Sale Securities link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Redeemable Convertible Preferred Stock and Conversion Feature Liability link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Stock-based compensation link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Notes Receivable (Tables) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Investment in Available-for-Sale Securities (Tables) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Redeemable Convertible Preferred Stock and Conversion Feature Liability (Tables) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Stock-based compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Income (Loss) Per Share (Details Textual) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Notes Receivable (Details) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Notes Receivable (Details Textual) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - Investment in Available-for-Sale Securities (Details) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - Investment in Available-for-Sale Securities (Details 1) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details 1) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details Textual) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - Stock-based compensation (Details) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - Stock-based compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - Related Party Transactions (Details Textual) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - Commitments and Contingencies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 135 - Disclosure - Subsequent Event (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 10 issm-20160930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 issm-20160930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 issm-20160930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 13 issm-20160930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2016
Oct. 21, 2016
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2016  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q3  
Entity Registrant Name INTEGRATED SURGICAL SYSTEMS INC  
Entity Central Index Key 0000894871  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol ISSM  
Entity Common Stock, Shares Outstanding   9,530,379
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 479,187 $ 545,705
Investments in available-for-sale securities 1,097,470 1,776,185
Notes receivable 638,351 0
Other current assets 42,846 29,928
Total current assets 2,257,854 2,351,818
Total Assets 2,257,854 2,351,818
Current liabilities:    
Accounts payable 68,984 9,631
Conversion feature liability 88,395 76,343
Total current liabilities 157,379 85,974
Commitments and contingencies
Redeemable convertible preferred stock, $0.01 par value, 1,000,000 shares authorized; 168 shares issued and outstanding ($168,496 aggregate liquidation value) 168,496 168,496
Stockholders’ equity:    
Common stock, $0.01 par value, 100,000,000 shares authorized; 9,483,503 and 9,282,981 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively 94,835 92,829
Common stock to be issued 9,375 12,500
Additional paid-in capital 64,543,421 64,514,177
Accumulated deficit (62,738,143) (62,527,454)
Accumulated other comprehensive income 22,491 5,296
Total stockholders’ equity 1,931,979 2,097,348
Total liabilities and stockholders’ equity $ 2,257,854 $ 2,351,818
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Balance Sheets [Parenthetical] - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 9,483,503 9,282,981
Common stock, shares outstanding 9,483,503 9,282,981
Redeemable convertible preferred stock [Member]    
Temporary equity, par value (in dollars per share) $ 0.01 $ 0.01
Temporary equity, shares authorized 1,000,000 1,000,000
Temporary equity, shares issued 168 168
Temporary equity, shares outstanding 168 168
Temporary equity, liquidation preference value $ 168,496 $ 168,496
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Statements of Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Operating Expenses        
General and administrative expenses $ 102,009 $ 49,640 $ 220,900 $ 179,694
Loss from operations (102,009) (49,640) (220,900) (179,694)
Other income (expense)        
Interest and dividend income, net 10,637 7,765 20,188 25,710
Change in fair value of conversion feature (2,858) (10,463) (12,052) (11,001)
Realized gain on available-for-sale securities 68 217 2,875 1,734
Total other income 7,847 (2,481) 11,011 16,443
Loss before income taxes     (209,889) (163,251)
Income taxes     800 800
Net loss (94,162) (52,121) (210,689) (164,051)
Other comprehensive income (loss)        
Unrealized gain (loss) on available-for-sale securities before reclassification, net of tax 4,036 (3,370) 20,070 (2,883)
Reclassification adjustment for gains, net of tax (68) (217) (2,875) (1,879)
Other comprehensive income (loss) 3,968 (3,587) 17,195 (4,762)
Comprehensive loss $ (90,194) $ (55,708) $ (193,494) $ (168,813)
Loss per share:        
Basic (in dollar per share) $ (0.01) $ (0.01) $ (0.02) $ (0.02)
Diluted (in dollar per share) $ (0.01) $ (0.01) $ (0.02) $ (0.02)
Weighted average number of shares outstanding        
Basic (in shares) 9,476,497 9,190,589 9,416,859 9,107,461
Diluted (in shares) 9,476,497 9,190,589 9,416,859 9,107,461
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net loss $ (210,689) $ (164,051)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of conversion feature 12,052 11,001
Stock based compensation 28,125 37,500
Realized gains on available-for-sale securities (2,875) (1,734)
Changes in operating assets and liabilities:    
Other current assets (12,918) (9,792)
Accounts payable and accrued liabilities 59,353 (8,474)
Net cash used in operating activities (126,952) (135,550)
Cash flows from investing activities:    
Notes receivable (638,351) 0
Purchases of available for sale securities 0 (1,221,185)
Proceeds received from sales of available-for-sale securities 0 9,200
Proceeds received from maturities of available-for-sale securities 698,785 1,146,754
Net cash provided by (used in) investing activities 60,434 (65,231)
Net decrease in cash and cash equivalents (66,518) (200,781)
Cash and cash equivalents at beginning of period 545,705 542,215
Cash and cash equivalents at end of period 479,187 341,434
Supplemental non-cash disclosure:    
Unrealized gain (loss) on available-for-sale securities $ 17,195 $ (4,762)
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Statement of Changes in Stockholders' Equity - 9 months ended Sep. 30, 2016 - USD ($)
Total
Common Stock [Member]
Common Stock To Be Issued [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2015 $ 2,097,348 $ 92,829 $ 12,500 $ 64,514,177 $ 5,296 $ (62,527,454)
Balance (in shares) at Dec. 31, 2015   9,282,981 83,334      
Stock-based compensation 18,750 $ 2,006 $ (12,500) 29,244 0 0
Stock-based compensation (in shares)   200,522 (83,334)      
Common stock to be issued 9,375 $ 0 $ 9,375 0 0 0
Common stock to be issued (in shares)   0 46,876      
Comprehensive income (loss)            
Net loss (210,689) $ 0 $ 0 0 0 (210,689)
Other Comprehensive income            
Net unrealized gain on investment in securities 17,195 0 0 0 17,195 0
Comprehensive income (loss) (193,494) 0 0 0 17,195 (210,689)
Balance at Sep. 30, 2016 $ 1,931,979 $ 94,835 $ 9,375 $ 64,543,421 $ 22,491 $ (62,738,143)
Balance (in shares) at Sep. 30, 2016   9,483,503 46,876      
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Organization and Operations
9 Months Ended
Sep. 30, 2016
Organization, Consolidation and Presentation Of Financial Statements [Abstract]  
Nature of Operations [Text Block]
1. Organization and Operations
 
Integrated Surgical Systems, Inc. (the “Company”) was incorporated in Delaware in 1990 to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures.  On June 28, 2007, the Company completed the sale of substantially all of its operating assets.  After completion of the sale, the Company no longer engaged in any business activities related to its former business, described above. The Company’s current operations are limited to completing a business combination or strategic alliance.
 
As of September 20, 2016, the Company signed a letter of intent to pursue the acquisition of theMaven Network, Inc. and on October 14, 2016, it signed a share exchange agreement with theMaven Network, Inc. and its shareholders to acquire the company as a wholly owned subsidiary. The closing is expected to take place within a few weeks, but before December 31, 2016.
 
If the Company does not complete the above mentioned acquisition of theMaven Network, Inc., then the Company does not have an estimate as to when it will complete a qualified merger, acquisition, or strategic alliance. There is no assurance that such opportunities will be available, or if available, upon favorable terms. If the Company is unsuccessful in completing a suitable merger, acquisition or strategic alliance, then the Board of Directors may liquidate the Company and distribute all its remaining assets, which consist primarily of cash and available-for-sale securities, to its stockholders.
 
The Company believes that if it identifies and completes a suitable merger, acquisition or strategic alliance target, it may need additional capital to complete the transaction or fund the continuing acquired operations. The Company, at this time, cannot estimate the amount of financing it may need for a transaction. There is no assurance that it will be able to obtain any required funding for a transaction, or that if it is obtainable it will be on acceptable terms.
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Significant Accounting Policies
9 Months Ended
Sep. 30, 2016
Accounting Policies [Abstract]  
Basis of Presentation and Significant Accounting Policies [Text Block]
2. Significant Accounting Policies
 
Basis of Presentation
 
The accompanying unaudited condensed financial statements and related notes have been prepared in accordance with the rules and regulations under Regulation S-X of the Securities and Exchange Commission for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed balance sheet at December 31, 2015 has been derived from the Company’s audited financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to present fairly the financial position as of September 30, 2016, the results of operations and cash flows for the nine months then ended have been included. These condensed financial statements should be read in conjunction with the financial statements of the Company and the Company’s management discussion and analysis included in the Company’s Form 10-K for the year ended December 31, 2015. Interim results are not necessarily indicative of the results for a full year.
 
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.  Actual results could materially differ from those estimates.
 
Cash and Cash Equivalents
 
Cash and cash equivalents include checking and money market accounts held in two financial institutions. The Company has a checking account at one institution with a balance of approximately $303,000 at September 30, 2016. The funds in this account are fully guaranteed by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company has a brokerage account with a second financial institution, with a cash balance of approximately $176,000 at September 30, 2016. Assets in this brokerage account are protected by the Securities Investor Protection Corporation (“SIPC”) up to $500,000 (with a limit of $250,000 for cash).   Throughout the year, the account balances at these institutions periodically exceed FDIC and SIPC insurance coverage; however, the Company has not experienced losses in these accounts and believes it is not exposed to any significant credit risk.
 
Stock-Based Compensation
 
Compensation costs for stock, warrants or options issued to employees and non-employees are based on the fair value method and accounted for in accordance with FASB ASC 718, ” Compensation – Stock Compensation.”  The value of warrants and options are calculated using a Black-Scholes Model, using the market price of the Company’s common stock on the date of issuance for the employee options or warrants and the date of commitment for non-employee options or warrants, an expected dividend yield of zero, the expected life of the warrants or options and the expected volatility of the Company’s common stock.
 
Investments in Available-for-Sale Securities
 
The Company has a portfolio of investments in available-for-sale debt securities, which consist of fixed income debt securities, and which are accounted for in accordance with FASB ASC 320, “Investments - Debt and Equity Securities.”  Management determines the appropriate classification of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date.  Available-for-sale securities are stated at fair value, and unrealized holding gains and losses, net of the related deferred tax effect, if any, are reported as other comprehensive income, a separate component of stockholders’ equity.
 
Fair Value Measurement
 
FASB ASC 820 “Fair Value Measurements and Disclosures” clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, FASB ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:
 
· Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
 
· Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.
 
· Level 3 - Unobservable inputs which are supported by little or no market activity.
 
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
 
In accordance with FASB ASC 820, the Company measures its cash equivalents, investments in available-for-sale securities, and derivative liability at fair value. The company classifies its cash equivalents and investments in available for sale securities within Level 1 or Level 2 in the fair value hierarchy because the company uses quoted market prices or alternative pricing sources and models utilizing observable market inputs to determine their fair value. The Company’s derivative liability is classified within Level 3.
 
The carrying value of other current assets and liabilities are considered to be representative of their respective fair values because of the short-term nature of those instruments.
 
Income Taxes
 
Deferred income taxes have been provided for temporary differences between financial statement and income tax reporting under the liability method, using expected tax rates and laws that are expected to be in effect when the differences are expected to reverse.  A valuation allowance is provided when realization is not considered more likely than not.
 
The Company applies the provisions of FASB ASC 740, “Income Taxes.”  ASC 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
 
The Company’s policy is to classify expenses as a result of income tax assessments as interest expense for interest charges and as penalties in general and administrative expenses for penalty assessments.
 
Recently Issued Accounting Pronouncements
  
Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income (Loss) Per Share
9 Months Ended
Sep. 30, 2016
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
3.  Income (Loss) Per Share
 
Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period plus dilutive common stock equivalents, using the treasury stock method.
 
Common stock equivalents for convertible preferred stock of 1,101,281 and 1,321,537 shares were excluded from the calculation of loss per share for the nine months and three months ended September 30, 2016 and 2015, respectively, because they were not dilutive; these shares would have been dilutive if the Company had not had a net loss for the these periods.
 
Stock options for the purchase of 175,000 and 200,000 shares of the Company’s common stock were excluded from the calculation of income per share for the nine months and three months ended September 30, 2016 and 2015, respectively, because they were anti-dilutive.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Notes Receivable
9 Months Ended
Sep. 30, 2016
Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]  
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]
4.  Notes Receivable
 
The Company has the following notes receivable:
 
Issue Date
 
September 30, 2016
(Unaudited)
 
December 31, 2015
 
August 11, 2016
 
$
155,451
 
$
-
 
September 14, 2016
 
 
357,900
 
 
-
 
September 26, 2016
 
 
125,000
 
 
-
 
 
 
$
638,351
 
$
-
 
 
On August 11, 2016, the Company entered into a term note agreement (“Term Note”) with theMaven Network, Inc. (“Borrower”) for a loan of $150,000, plus expenses incurred by the Company in connection with the execution of this term note. The note is due at the earlier of (1) February 13, 2017, or (ii) the occurrence of certain events, as defined in the agreement. The note is secured by a personal guarantee of the principal officer of the Borrower (“Borrower Officer”). The $150,000 amount was guaranteed by MDB until the extension of additional principal as described below. The principal amount as of August 11, 2016, including expenses incurred by the Company, is $155,451. The Term Note provides that the principal amount of the loan would be increased by $350,000 (“Additional Amount”), plus expenses incurred by the Company in connection with the Term Note, if and when the Borrower Officer provides additional security for the total loan amount in the form of a mortgage on certain real estate (the “Mortgage”).  The Mortgage was provided in late August and the Company subsequently extended the Additional Amount to Borrower.  The interest rate on the borrowed amount is 8% per annum.  The loan agreement contains additional covenants, representations and events of default.
 
The Term Note was amended on August 25, 2016 to provide details of the Mortgage.  The Term Note was further amended on September 26, 2016 to extend an additional $125,000 to the Borrower.  This additional $125,000 of principle is guaranteed by MDB. As of September 30, 2016, the aggregated principal amount under the Term Note, including expenses incurred by the Company, is $638,351.
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Investment in Available-for-Sale Securities
9 Months Ended
Sep. 30, 2016
Available-For-Sale Securities [Abstract]  
Available For Sale Securities Disclosure [Text Block]
5.  Investment in Available-for-Sale Securities
 
The following is a summary of the Company’s investments in available-for-sale securities as of September 30, 2016 (unaudited):
 
 
 
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
 
U.S. federal agency securities
 
$
4,898
 
$
53
 
$
-
 
$
4,951
 
Municipal securities
 
 
311,517
 
 
1,582
 
 
(236)
 
 
312,863
 
Certificates of deposit
 
 
741,769
 
 
31,612
 
 
(10,736)
 
 
762,645
 
Corporate debt securities
 
 
16,795
 
 
216
 
 
-
 
 
17,011
 
 
 
$
1,074,979
 
$
33,463
 
$
(10,972)
 
$
1,097,470
 
 
The following is a summary of the Company’s investments in available-for-sale securities as of December 31, 2015:
 
 
 
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
 
U.S. federal agency securities
 
$
4,830
 
$
55
 
$
-
 
$
4,885
 
Municipal securities
 
 
492,237
 
 
789
 
 
(980)
 
 
492,046
 
Certificates of deposit
 
 
1,256,649
 
 
20,182
 
 
(14,865)
 
 
1,261,966
 
Corporate debt securities
 
 
17,173
 
 
115
 
 
-
 
 
17,288
 
 
 
$
1,770,889
 
$
21,141
 
$
(15,845)
 
$
1,776,185
 
   
The cost and fair value of investments in fixed income available-for-sale debt securities, by contractual maturity, as of September 30, 2016 (unaudited), are as follows:
 
 
 
Cost
 
Fair
Value
 
Due within one year
 
$
739,361
 
$
757,136
 
Due after one year through three years
 
 
164,331
 
 
165,934
 
Due after three years
 
 
171,287
 
 
174,400
 
 
 
$
1,074,979
 
$
1,097,470
 
 
Expected maturities will differ from contractual maturities because the issuers of certain debt securities have the right to call or prepay their obligations without any penalties.  The Company has classified the entire fair value of its investments in available-for-sale debt securities as current assets in the accompanying condensed balance sheets.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Redeemable Convertible Preferred Stock and Conversion Feature Liability
9 Months Ended
Sep. 30, 2016
Temporary Equity Disclosure [Abstract]  
Temporary Equity Disclosure [Text Block]
6.  Redeemable Convertible Preferred Stock and Conversion Feature Liability
 
The Company’s Certificate of Incorporation authorized 1,000,000 shares of undesignated, serial preferred stock. Preferred stock may be issued from time to time in one or more series. The Board of Directors is authorized to determine the rights, preferences, privileges, and restrictions granted to and imposed upon any wholly unissued series of preferred stock and designation of any such series without any further vote or action by the Company’s stockholders.
 
As of September 30, 2016 and December 31, 2015, the Company’s only outstanding series of convertible preferred stock is the Series G Convertible Preferred Stock (“Series G”).
 
The Series G stock has a stated value of $1,000 per share, and is convertible into common stock at a conversion price equal to 85% of the lowest sale price of the common stock on its listed market over the five trading days preceding the date of conversion (“Beneficial Conversion Feature”), subject to a maximum conversion price. The number of shares of common stock that may be converted is determined by dividing the stated value of the number of shares of Series G to be converted by the conversion price. The Company may elect to pay the Series G holder in cash at the current market price multiplied by the number of shares of common stock issuable upon conversion.
 
For the nine months ended September 30, 2016 and the year ended December 31, 2015, no shares of Series G were converted into shares of common stock.  At September 30, 2016 and December 31, 2015, the outstanding Series G shares were convertible into a minimum of 1,101,281 and 1,321,537 shares of common stock, respectively.
 
Upon a change in control, sale of or similar transaction, as defined in the Certificate of Designation for the Series G, each holder of the Series G has the option to deem such transaction as a liquidation and may redeem his or her shares at the liquidation value of $1,000, per share, for an aggregate amount of $168,496.  The sale of all the assets on June 28, 2007 triggered the preferred stockholders’ redemption option.  As such redemption is not in the control of the Company, the Series G stock has been accounted for as if it was redeemable preferred stock and is classified on the balance sheet between liabilities and stockholders’ equity.
 
The conversion feature of the preferred stock is considered a derivative according to ASC 815 “Derivatives and Hedging”, therefore, the fair value of the derivative is reflected in the financial statements as a liability, which was determined to be $88,395 as of September 30, 2016 (unaudited), and has been included as “conversion feature liability” on the accompanying condensed balance sheets. As of December 31, 2015, the fair value of the derivative was determined to be $76,343.
 
The fair value of the conversion feature liability is calculated under a Black-Scholes Model, using the market price of the Company’s common stock on each of the balance sheet dates presented, the expected dividend yield, the expected life of the redemption and the expected volatility of the Company’s common stock.
 
The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and considering factors specific to the conversion feature liability. Since some of the assumptions used by the Company are unobservable, the conversion feature liability is classified within the level 3 hierarchy in the fair value measurement.
 
The expected volatility of the conversion feature liability was based on the historical volatility of the Company’s common stock. The expected life assumption was based on the expected remaining life of the underlying preferred stock redemption. The risk-free interest rate for the expected term of the conversion feature liability was based on the average market rate on U.S. treasury securities in effect during the applicable quarter. The dividend yield reflected historical experience as well as future expectations over the expected term of the underlying preferred stock redemption. Therefore, the fair value of the conversion feature liability is sensitive to changes in above assumptions and changes of the Company’s common stock price.
 
The table below shows the quantitative information about the significant unobservable inputs used in the fair value measurement of level 3 conversion feature liability:
 
 
 
September 30, 2016
 
 
 
(unaudited)
 
 
 
 
 
 
Expected remaining life of the redemption in years
 
 
1.0
 
Risk free interest rate
 
 
0.59
%
Expected annual volatility
 
 
77.70
%
Annual rate of dividends
 
 
0
%
 
The changes in the fair value of the derivative are as follows:
 
Balance as of January 1, 2016
 
$
76,343
 
Decrease of fair value
 
 
12,052
 
 
 
 
 
 
Ending balance as of September 30, 2016 (unaudited)
 
$
88,395
 
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-based compensation
9 Months Ended
Sep. 30, 2016
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
7.  Stock-based compensation
 
For the nine months ended September 30, 2016, the Company had no activity related to stock options. As of September 30, 2016, a summary of options outstanding under the Company’s 2014 options grant was as follows:
 
Range of
Exercise
Price
 
Weighted-
Average Remaining
Contractual Life (Years)
 
Number
Outstanding
 
Weighted-
Average
Exercise
Price
 
Number
Exercisable
 
Weighted-
Average
Exercise
Price
 
$
0.17
 
 
2.63
 
 
175,000
 
$
0.17
 
 
175,000
 
$
0.17
 
 
The Company agreed to compensate each director in the amount of $25,000 per year, payable quarterly, beginning on January 1, 2016. Such compensation may be paid to each director either in the form of cash, or the Company’s common stock or a combination thereof at the election of such director which may be changed during the year with respect to future payments. The Company compensated one of its directors by issuing common stock, one of its directors by issuing common stock and in cash, and the third director in cash for services rendered in 2016. The Company compensated two of its four directors by issuing common stock, and two directors in cash for services rendered in 2015. The number of shares issued to each director was determined based upon the equivalent cash compensation accrued divided by the closing price of the Company’s common stock on the date that the compensation is fully earned each quarter, which is the last day of such quarter. The Company recorded stock-based compensation expense of $9,375 and $28,125 for the three and nine months ended September 30, 2016 for two directors, which was recorded as common stock to be issued.
 
On January 11, 2016, the Company issued 41,667 shares of common stock to each of two directors as compensation for the three months ended December 31, 2015. These shares, totaling 83,334, were valued at a per share price of $0.15, or a total of $12,500.
 
On April 12, 2016, the Company issued 39,063 shares of common stock to one director, and 19,531 shares of common stock to a second director as compensation for the three months ended March 31, 2016. These shares, totaling 58,594, were valued at a per share price of $0.16, or a total of $9,375 (unaudited).
  
On July 11, 2016, the Company issued 39,063 shares of common stock to one director, and 19,531 shares of common stock to a second director as compensation for the three months ended June 30, 2016. These shares, totaling 58,594, were valued at a per share price of $0.16, or a total of $9,375 (unaudited).
 
On October 4, 2016, the Company issued 31,251 shares of common stock to one director, and 15,625 shares of common stock to a second director as compensation for the three months ended September 30, 2016. These shares, totaling 46,876, were valued at a per share price of $0.20, or a total of $9,375 (unaudited).
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions
9 Months Ended
Sep. 30, 2016
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
8.  Related Party Transactions
 
The Company entered into an Investment Banking Advisory Services agreement in November 2007 with MDB Capital Group LLC (“MDB”), and the parties extended this agreement indefinitely in April 2009.  The agreement may be terminated by either party upon 30-days written notice.
 
The Company has a securities investment account with MDB, consisting of (a) available-for-sale investments totaling $1,097,470, that include short-term federal securities of $4,951, and certificates of deposit, municipal securities and corporate debt securities totaling $1,092,519 at September 30, 2016 (unaudited), and (b) available-for-sale investments totaling $1,776,185, that include short-term federal securities of $4,885, certificates of deposit, municipal securities and corporate debt securities totaling $1,771,300 at December 31, 2015.
 
Mr. Christopher Marlett, the Chief Executive Officer and director of the Company, is also the Chief Executive Officer of MDB. Mr. Gary Schuman, who is the Chief Financial Officer of the Company, is also the Chief Financial Officer and Chief Compliance Officer of MDB.  The Company compensates for Mr. Schuman’s services in the amount of $3,000 per month, totaling $27,000 for the nine months ended September 30, 2016 and 2015 (unaudited).  Mr. Robert Levande, who is an officer and director of the Company, is also a senior managing director of MDB. In addition to shares of common stock (as discussed in Note 6), Mr. Levande was compensated $9,375 for his services as director for the nine months ended September 30, 2016 (unaudited).
 
MDB has guaranteed $125,000 of the principle amount due on the Term Note from theMaven Network, Inc. described in Note 4 above. This guarantee will terminate upon the completion of the acquisition of theMaven Network, Inc. which is described in Note 1 above and Note 10 below.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
9.  Commitments and Contingencies
 
From time to time, the Company may be subject to other claims and litigation arising in the ordinary course of business.  The Company is not currently a party to any legal proceedings that it believes would reasonably be expected to have a material adverse effect on the Company’s business, financial condition or results of operations.
 
The Company may have a liability for additional state franchise taxes payable in the amount of approximately $44,000, plus interest at 18% per annum, for the years 2008-2014. Because of state statutory provisions, the underpaid amount will only be due once assessed and demanded by the state.  The tax liability and associated interest has not been included as an accrued liability because management has determined that the likelihood of the state making the assessment is low.  Depending on circumstances, management may change its estimate of the probability of an assessment and establish either an accrual or record a payment for the tax liability if assessed.
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Subsequent Events
9 Months Ended
Sep. 30, 2016
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
10.  Subsequent Events
 
On October 14, 2016, the Company entered into a share exchange agreement under which the company will acquire theMaven Network, Inc. (“Maven”) in an exchange of shares, whereby Maven will become a wholly owned subsidiary of the Company.  The number of shares of the Company to be issued for the equity of Maven will be determined by a formula, and it is anticipated that the Company will issue approximately 55% of its issued and outstanding common stock immediately after the transaction.  At the closing, it is agreed that one of Maven’s directors will become a director of the Company and several of their officers will also become officers of the Company under their current employment arrangements. The consummation of the acquisition is subject to various conditions precedent, as defined in the agreement, for each of the parties to the agreement. The Company anticipates the closing taking place within a few weeks.
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2016
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
 
The accompanying unaudited condensed financial statements and related notes have been prepared in accordance with the rules and regulations under Regulation S-X of the Securities and Exchange Commission for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed balance sheet at December 31, 2015 has been derived from the Company’s audited financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to present fairly the financial position as of September 30, 2016, the results of operations and cash flows for the nine months then ended have been included. These condensed financial statements should be read in conjunction with the financial statements of the Company and the Company’s management discussion and analysis included in the Company’s Form 10-K for the year ended December 31, 2015. Interim results are not necessarily indicative of the results for a full year.
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.  Actual results could materially differ from those estimates.
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
 
Cash and cash equivalents include checking and money market accounts held in two financial institutions. The Company has a checking account at one institution with a balance of approximately $303,000 at September 30, 2016. The funds in this account are fully guaranteed by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company has a brokerage account with a second financial institution, with a cash balance of approximately $176,000 at September 30, 2016. Assets in this brokerage account are protected by the Securities Investor Protection Corporation (“SIPC”) up to $500,000 (with a limit of $250,000 for cash).   Throughout the year, the account balances at these institutions periodically exceed FDIC and SIPC insurance coverage; however, the Company has not experienced losses in these accounts and believes it is not exposed to any significant credit risk.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-Based Compensation
 
Compensation costs for stock, warrants or options issued to employees and non-employees are based on the fair value method and accounted for in accordance with FASB ASC 718, ” Compensation – Stock Compensation.”  The value of warrants and options are calculated using a Black-Scholes Model, using the market price of the Company’s common stock on the date of issuance for the employee options or warrants and the date of commitment for non-employee options or warrants, an expected dividend yield of zero, the expected life of the warrants or options and the expected volatility of the Company’s common stock.
Marketable Securities, Available-for-sale Securities, Policy [Policy Text Block]
Investments in Available-for-Sale Securities
 
The Company has a portfolio of investments in available-for-sale debt securities, which consist of fixed income debt securities, and which are accounted for in accordance with FASB ASC 320, “Investments - Debt and Equity Securities.”  Management determines the appropriate classification of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date.  Available-for-sale securities are stated at fair value, and unrealized holding gains and losses, net of the related deferred tax effect, if any, are reported as other comprehensive income, a separate component of stockholders’ equity.
Fair Value Measurement, Policy [Policy Text Block]
Fair Value Measurement
 
FASB ASC 820 “Fair Value Measurements and Disclosures” clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, FASB ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:
 
· Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
 
· Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.
 
· Level 3 - Unobservable inputs which are supported by little or no market activity.
 
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
 
In accordance with FASB ASC 820, the Company measures its cash equivalents, investments in available-for-sale securities, and derivative liability at fair value. The company classifies its cash equivalents and investments in available for sale securities within Level 1 or Level 2 in the fair value hierarchy because the company uses quoted market prices or alternative pricing sources and models utilizing observable market inputs to determine their fair value. The Company’s derivative liability is classified within Level 3.
 
The carrying value of other current assets and liabilities are considered to be representative of their respective fair values because of the short-term nature of those instruments.
Income Tax, Policy [Policy Text Block]
Income Taxes
 
Deferred income taxes have been provided for temporary differences between financial statement and income tax reporting under the liability method, using expected tax rates and laws that are expected to be in effect when the differences are expected to reverse.  A valuation allowance is provided when realization is not considered more likely than not.
 
The Company applies the provisions of FASB ASC 740, “Income Taxes.”  ASC 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
 
The Company’s policy is to classify expenses as a result of income tax assessments as interest expense for interest charges and as penalties in general and administrative expenses for penalty assessments.
Recently Announced Accounting Pronouncements, Policy [Policy Text Block]
Recently Issued Accounting Pronouncements
  
Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Notes Receivable (Tables)
9 Months Ended
Sep. 30, 2016
Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
The Company has the following notes receivable:
 
Issue Date
 
September 30, 2016
(Unaudited)
 
December 31, 2015
 
August 11, 2016
 
$
155,451
 
$
-
 
September 14, 2016
 
 
357,900
 
 
-
 
September 26, 2016
 
 
125,000
 
 
-
 
 
 
$
638,351
 
$
-
 
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Investment in Available-for-Sale Securities (Tables)
9 Months Ended
Sep. 30, 2016
Available-For-Sale Securities [Abstract]  
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]
The following is a summary of the Company’s investments in available-for-sale securities as of September 30, 2016 (unaudited):
 
 
 
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
 
U.S. federal agency securities
 
$
4,898
 
$
53
 
$
-
 
$
4,951
 
Municipal securities
 
 
311,517
 
 
1,582
 
 
(236)
 
 
312,863
 
Certificates of deposit
 
 
741,769
 
 
31,612
 
 
(10,736)
 
 
762,645
 
Corporate debt securities
 
 
16,795
 
 
216
 
 
-
 
 
17,011
 
 
 
$
1,074,979
 
$
33,463
 
$
(10,972)
 
$
1,097,470
 
 
The following is a summary of the Company’s investments in available-for-sale securities as of December 31, 2015:
 
 
 
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
 
U.S. federal agency securities
 
$
4,830
 
$
55
 
$
-
 
$
4,885
 
Municipal securities
 
 
492,237
 
 
789
 
 
(980)
 
 
492,046
 
Certificates of deposit
 
 
1,256,649
 
 
20,182
 
 
(14,865)
 
 
1,261,966
 
Corporate debt securities
 
 
17,173
 
 
115
 
 
-
 
 
17,288
 
 
 
$
1,770,889
 
$
21,141
 
$
(15,845)
 
$
1,776,185
 
Available-for-sale Securities [Table Text Block]
The cost and fair value of investments in fixed income available-for-sale debt securities, by contractual maturity, as of September 30, 2016 (unaudited), are as follows:
 
 
 
Cost
 
Fair
Value
 
Due within one year
 
$
739,361
 
$
757,136
 
Due after one year through three years
 
 
164,331
 
 
165,934
 
Due after three years
 
 
171,287
 
 
174,400
 
 
 
$
1,074,979
 
$
1,097,470
 
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Redeemable Convertible Preferred Stock and Conversion Feature Liability (Tables)
9 Months Ended
Sep. 30, 2016
Temporary Equity Disclosure [Abstract]  
Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]
The table below shows the quantitative information about the significant unobservable inputs used in the fair value measurement of level 3 conversion feature liability:
 
 
 
September 30, 2016
 
 
 
(unaudited)
 
 
 
 
 
 
Expected remaining life of the redemption in years
 
 
1.0
 
Risk free interest rate
 
 
0.59
%
Expected annual volatility
 
 
77.70
%
Annual rate of dividends
 
 
0
%
Schedule of Derivative Liabilities at Fair Value [Table Text Block]
The changes in the fair value of the derivative are as follows:
 
Balance as of January 1, 2016
 
$
76,343
 
Decrease of fair value
 
 
12,052
 
 
 
 
 
 
Ending balance as of September 30, 2016 (unaudited)
 
$
88,395
 
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-based compensation (Tables)
9 Months Ended
Sep. 30, 2016
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]
As of September 30, 2016, a summary of options outstanding under the Company’s 2014 options grant was as follows:
 
Range of
Exercise
Price
 
Weighted-
Average Remaining
Contractual Life (Years)
 
Number
Outstanding
 
Weighted-
Average
Exercise
Price
 
Number
Exercisable
 
Weighted-
Average
Exercise
Price
 
$
0.17
 
 
2.63
 
 
175,000
 
$
0.17
 
 
175,000
 
$
0.17
 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Significant Accounting Policies (Details Textual)
Sep. 30, 2016
USD ($)
Significant Accounting Policies [Line Items]  
Checking Account $ 303,000
Assets Guaranteed By Federal Deposit Insurance Corporation Maximum 250,000
Money Market Funds, at Carrying Value 176,000
Maximum Amount Of Assets Protected By Securities Investor Protection Corporation In Brokerage Account 250,000
Maximum [Member]  
Significant Accounting Policies [Line Items]  
Maximum Amount Of Assets Protected By Securities Investor Protection Corporation In Brokerage Account $ 500,000
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income (Loss) Per Share (Details Textual) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Incremental Common Shares Attributable to Conversion of Preferred Stock 1,101,281 1,321,537 1,101,281 1,321,537
Equity Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 175,000 200,000 175,000 200,000
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Notes Receivable (Details) - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Accounts and Notes Receivable, Net $ 638,351 $ 0
August 11, 2016 [Member]    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Accounts and Notes Receivable, Net 155,451 0
September 14, 2016 [Member]    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Accounts and Notes Receivable, Net 357,900 0
September 26, 2016 [Member]    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Accounts and Notes Receivable, Net $ 125,000 $ 0
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Notes Receivable (Details Textual) - USD ($)
1 Months Ended
Aug. 11, 2016
Sep. 26, 2016
Sep. 30, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Debt Instrument, Face Amount $ 150,000    
Term Note [Member]      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Long-term Debt, Gross 155,451   $ 638,351
Debt Instrument, Increase (Decrease), Net $ 350,000 $ 125,000  
Debt Instrument, Interest Rate, Stated Percentage 8.00%    
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
Investment in Available-for-Sale Securities (Details) - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Schedule of Available-for-sale Securities [Line Items]    
Available-for-sale Securities, Cost $ 1,074,979 $ 1,770,889
Available-for-sale Securities, Unrealized Gains 33,463 21,141
Available-for-sale Securities, Unrealized Losses (10,972) (15,845)
Available-for-sale Securities, Fair Value 1,097,470 1,776,185
U.S. federal agency securities [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Available-for-sale Securities, Cost 4,898 4,830
Available-for-sale Securities, Unrealized Gains 53 55
Available-for-sale Securities, Unrealized Losses 0 0
Available-for-sale Securities, Fair Value 4,951 4,885
Municipal securities [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Available-for-sale Securities, Cost 311,517 492,237
Available-for-sale Securities, Unrealized Gains 1,582 789
Available-for-sale Securities, Unrealized Losses (236) (980)
Available-for-sale Securities, Fair Value 312,863 492,046
Certificates of deposit [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Available-for-sale Securities, Cost 741,769 1,256,649
Available-for-sale Securities, Unrealized Gains 31,612 20,182
Available-for-sale Securities, Unrealized Losses (10,736) (14,865)
Available-for-sale Securities, Fair Value 762,645 1,261,966
Corporate debt securities [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Available-for-sale Securities, Cost 16,795 17,173
Available-for-sale Securities, Unrealized Gains 216 115
Available-for-sale Securities, Unrealized Losses 0 0
Available-for-sale Securities, Fair Value $ 17,011 $ 17,288
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
Investment in Available-for-Sale Securities (Details 1) - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Schedule of Available-for-sale Securities [Line Items]    
Due within one year, Cost $ 739,361  
Due after one year through three years, Cost 164,331  
Due after three years, Cost 171,287  
Available-for-sale Securities, Amortized Cost, Total 1,074,979  
Due within one year, Fair Value 757,136  
Due after one year through three years, Fair Value 165,934  
Due after three years, Fair Value 174,400  
Available-for-sale Securities, Fair Value, Total $ 1,097,470 $ 1,776,185
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details) - Fair Value, Inputs, Level 3 [Member]
9 Months Ended
Sep. 30, 2016
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]  
Expected remaining life of the redemption in years 1 year
Risk free interest rate 0.59%
Expected annual volatility 77.70%
Annual rate of dividends 0.00%
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details 1)
9 Months Ended
Sep. 30, 2016
USD ($)
Derivatives, Fair Value [Line Items]  
Balance as of January 1, 2016 $ 76,343
Decrease of fair value 12,052
Ending balance as of September 30, 2016 $ 88,395
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details Textual) - USD ($)
9 Months Ended
Sep. 30, 2016
Dec. 31, 2015
Temporary Equity [Line Items]    
Preferred Stock, Shares Authorized 1,000,000  
Derivative Liabilities, Current $ 88,395 $ 76,343
Series G Preferred Stock [Member]    
Temporary Equity [Line Items]    
Preferred Stock, Par or Stated Value Per Share $ 1,000  
Convertible Preferred Stock, Terms of Conversion conversion price equal to 85% of the lowest sale price of the common stock on its listed market over the five trading days preceding the date of conversion (Beneficial Conversion Feature), subject to a maximum conversion price.  
Preferred Stock, Shares Outstanding 1,101,281 1,321,537
Preferred Stock, Liquidation Preference Per Share $ 1,000  
Preferred Stock, Liquidation Preference, Value $ 168,496  
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-based compensation (Details)
9 Months Ended
Sep. 30, 2016
$ / shares
shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of Exercise Price $ 0.17
Weighted-Average Remaining Contractual Life (Years) 2 years 7 months 17 days
Number Outstanding | shares 175,000
Weighted-Average Exercise Price, Outstanding $ 0.17
Number Exercisable | shares 175,000
Weighted-Average Exercise Price, Exercisable $ 0.17
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-based compensation (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 11, 2016
Oct. 31, 2016
Jul. 31, 2016
Apr. 30, 2016
Sep. 30, 2016
Sep. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]            
Stock Issuance Date Jan. 11, 2016          
Stock Issued During Period, Shares, New Issues 83,334   58,594 58,594    
Stock Issued During Period Per Share Value Of New Issues $ 0.15   $ 0.16 $ 0.16    
Stock Issued During Period, Value, New Issues $ 12,500   $ 9,375 $ 9,375    
Deferred Compensation Liability, Current, Total         $ 25,000 $ 25,000
Subsequent Event [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]            
Stock Issued During Period, Shares, New Issues   46,876        
Stock Issued During Period Per Share Value Of New Issues   $ 0.20        
Stock Issued During Period, Value, New Issues   $ 9,375        
Directors Two [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]            
Stock Issued During Period, Shares, New Issues 41,667   19,531 19,531    
Stock Issued During Period, Value, New Issues         $ 9,375 $ 28,125
Directors Two [Member] | Subsequent Event [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]            
Stock Issued During Period, Shares, New Issues   15,625        
Director One [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]            
Stock Issued During Period, Shares, New Issues     39,063 39,063    
Director One [Member] | Subsequent Event [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]            
Stock Issued During Period, Shares, New Issues   31,251        
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions (Details Textual) - USD ($)
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 26, 2016
Dec. 31, 2015
Related Party Transaction [Line Items]        
Available-For-Sale Securities, Current $ 1,097,470     $ 1,776,185
Robert Levande [Member]        
Related Party Transaction [Line Items]        
Reimbursement For Related Party Services 9,375      
MDB Capital Group LLC [Member]        
Related Party Transaction [Line Items]        
Available-For-Sale Securities, Current 1,097,470     1,776,185
Federal Securities Current 4,951     4,885
Certificates Of Deposit Municipal Securities and Corporate Bonds 1,092,519     $ 1,771,300
Reimbursement For Related Party Services Per Month 3,000      
Reimbursement For Related Party Services $ 27,000 $ 27,000    
Loans and Leases Receivable, Collateral for Secured Borrowings     $ 125,000  
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments and Contingencies (Details Textual)
Sep. 30, 2016
USD ($)
Commitments And Contingencies [Line Items]  
Interest Rate Per Month, Percentage 18.00%
Franchise Tax Payable $ 44,000
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
Subsequent Event (Details Textual)
Oct. 14, 2016
Subsequent Event [Member]  
Subsequent Event [Line Items]  
Issued And Outstanding Common Stock, Percentage 55.00%
EXCEL 49 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 74 147 1 false 23 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.issm.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - Condensed Balance Sheets Sheet http://www.issm.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 103 - Statement - Condensed Balance Sheets [Parenthetical] Sheet http://www.issm.com/role/CondensedBalanceSheetsParenthetical Condensed Balance Sheets [Parenthetical] Statements 3 false false R4.htm 104 - Statement - Condensed Statements of Comprehensive Loss Sheet http://www.issm.com/role/CondensedStatementsOfComprehensiveLoss Condensed Statements of Comprehensive Loss Statements 4 false false R5.htm 105 - Statement - Condensed Statements of Cash Flows Sheet http://www.issm.com/role/CondensedStatementsOfCashFlows Condensed Statements of Cash Flows Statements 5 false false R6.htm 106 - Statement - Condensed Statement of Changes in Stockholders' Equity Sheet http://www.issm.com/role/CondensedStatementOfChangesInStockholdersEquity Condensed Statement of Changes in Stockholders' Equity Statements 6 false false R7.htm 107 - Disclosure - Organization and Operations Sheet http://www.issm.com/role/OrganizationAndOperations Organization and Operations Notes 7 false false R8.htm 108 - Disclosure - Significant Accounting Policies Sheet http://www.issm.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 109 - Disclosure - Income (Loss) Per Share Sheet http://www.issm.com/role/IncomeLossPerShare Income (Loss) Per Share Notes 9 false false R10.htm 110 - Disclosure - Notes Receivable Notes http://www.issm.com/role/NotesReceivable Notes Receivable Notes 10 false false R11.htm 111 - Disclosure - Investment in Available-for-Sale Securities Sheet http://www.issm.com/role/InvestmentInAvailableforsaleSecurities Investment in Available-for-Sale Securities Notes 11 false false R12.htm 112 - Disclosure - Redeemable Convertible Preferred Stock and Conversion Feature Liability Sheet http://www.issm.com/role/RedeemableConvertiblePreferredStockAndConversionFeatureLiability Redeemable Convertible Preferred Stock and Conversion Feature Liability Notes 12 false false R13.htm 113 - Disclosure - Stock-based compensation Sheet http://www.issm.com/role/StockbasedCompensation Stock-based compensation Notes 13 false false R14.htm 114 - Disclosure - Related Party Transactions Sheet http://www.issm.com/role/RelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 115 - Disclosure - Commitments and Contingencies Sheet http://www.issm.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 116 - Disclosure - Subsequent Events Sheet http://www.issm.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 117 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.issm.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.issm.com/role/SignificantAccountingPolicies 17 false false R18.htm 118 - Disclosure - Notes Receivable (Tables) Notes http://www.issm.com/role/NotesReceivableTables Notes Receivable (Tables) Tables http://www.issm.com/role/NotesReceivable 18 false false R19.htm 119 - Disclosure - Investment in Available-for-Sale Securities (Tables) Sheet http://www.issm.com/role/InvestmentInAvailableforsaleSecuritiesTables Investment in Available-for-Sale Securities (Tables) Tables http://www.issm.com/role/InvestmentInAvailableforsaleSecurities 19 false false R20.htm 120 - Disclosure - Redeemable Convertible Preferred Stock and Conversion Feature Liability (Tables) Sheet http://www.issm.com/role/RedeemableConvertiblePreferredStockAndConversionFeatureLiabilityTables Redeemable Convertible Preferred Stock and Conversion Feature Liability (Tables) Tables http://www.issm.com/role/RedeemableConvertiblePreferredStockAndConversionFeatureLiability 20 false false R21.htm 121 - Disclosure - Stock-based compensation (Tables) Sheet http://www.issm.com/role/StockbasedCompensationTables Stock-based compensation (Tables) Tables http://www.issm.com/role/StockbasedCompensation 21 false false R22.htm 122 - Disclosure - Significant Accounting Policies (Details Textual) Sheet http://www.issm.com/role/SignificantAccountingPoliciesDetailsTextual Significant Accounting Policies (Details Textual) Details http://www.issm.com/role/SignificantAccountingPoliciesPolicies 22 false false R23.htm 123 - Disclosure - Income (Loss) Per Share (Details Textual) Sheet http://www.issm.com/role/IncomeLossPerShareDetailsTextual Income (Loss) Per Share (Details Textual) Details http://www.issm.com/role/IncomeLossPerShare 23 false false R24.htm 124 - Disclosure - Notes Receivable (Details) Notes http://www.issm.com/role/NotesReceivableDetails Notes Receivable (Details) Details http://www.issm.com/role/NotesReceivableTables 24 false false R25.htm 125 - Disclosure - Notes Receivable (Details Textual) Notes http://www.issm.com/role/NotesReceivableDetailsTextual Notes Receivable (Details Textual) Details http://www.issm.com/role/NotesReceivableTables 25 false false R26.htm 126 - Disclosure - Investment in Available-for-Sale Securities (Details) Sheet http://www.issm.com/role/InvestmentInAvailableforsaleSecuritiesDetails Investment in Available-for-Sale Securities (Details) Details http://www.issm.com/role/InvestmentInAvailableforsaleSecuritiesTables 26 false false R27.htm 127 - Disclosure - Investment in Available-for-Sale Securities (Details 1) Sheet http://www.issm.com/role/InvestmentInAvailableforsaleSecuritiesDetails1 Investment in Available-for-Sale Securities (Details 1) Details http://www.issm.com/role/InvestmentInAvailableforsaleSecuritiesTables 27 false false R28.htm 128 - Disclosure - Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details) Sheet http://www.issm.com/role/RedeemableConvertiblePreferredStockAndConversionFeatureLiabilityDetails Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details) Details http://www.issm.com/role/RedeemableConvertiblePreferredStockAndConversionFeatureLiabilityTables 28 false false R29.htm 129 - Disclosure - Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details 1) Sheet http://www.issm.com/role/RedeemableConvertiblePreferredStockAndConversionFeatureLiabilityDetails1 Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details 1) Details http://www.issm.com/role/RedeemableConvertiblePreferredStockAndConversionFeatureLiabilityTables 29 false false R30.htm 130 - Disclosure - Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details Textual) Sheet http://www.issm.com/role/RedeemableConvertiblePreferredStockAndConversionFeatureLiabilityDetailsTextual Redeemable Convertible Preferred Stock and Conversion Feature Liability (Details Textual) Details http://www.issm.com/role/RedeemableConvertiblePreferredStockAndConversionFeatureLiabilityTables 30 false false R31.htm 131 - Disclosure - Stock-based compensation (Details) Sheet http://www.issm.com/role/StockbasedCompensationDetails Stock-based compensation (Details) Details http://www.issm.com/role/StockbasedCompensationTables 31 false false R32.htm 132 - Disclosure - Stock-based compensation (Details Textual) Sheet http://www.issm.com/role/StockbasedCompensationDetailsTextual Stock-based compensation (Details Textual) Details http://www.issm.com/role/StockbasedCompensationTables 32 false false R33.htm 133 - Disclosure - Related Party Transactions (Details Textual) Sheet http://www.issm.com/role/RelatedPartyTransactionsDetailsTextual Related Party Transactions (Details Textual) Details http://www.issm.com/role/RelatedPartyTransactions 33 false false R34.htm 134 - Disclosure - Commitments and Contingencies (Details Textual) Sheet http://www.issm.com/role/CommitmentsAndContingenciesDetailsTextual Commitments and Contingencies (Details Textual) Details http://www.issm.com/role/CommitmentsAndContingencies 34 false false R35.htm 135 - Disclosure - Subsequent Event (Details Textual) Sheet http://www.issm.com/role/SubsequentEventDetailsTextual Subsequent Event (Details Textual) Details http://www.issm.com/role/SubsequentEvents 35 false false All Reports Book All Reports issm-20160930.xml issm-20160930.xsd issm-20160930_cal.xml issm-20160930_def.xml issm-20160930_lab.xml issm-20160930_pre.xml true true ZIP 55 0001144204-16-130353-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-16-130353-xbrl.zip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bNQK)5;''G$/B$-WGZL4V>P%7BT0!7E09;+[*-4IYK"4M^GL4B MIE()]IIM2KCSO3'4^Q.RQ>E%U'F%7WGRA6BXFXNS15KI"JUT:/4&K692.DGE[$W M7Z+S3:QKX_&Y7VS!]_@Q*)MIE*<_8TX8;JAKX:;_G)<4*"R%"\]XA02Y$7%? M\- UB&(,5"^_XOW[-0=@,%$AJ>#''/@T+EBR#+L!XIW\3@(F*) M>Z$DW]5_1J^X0<$S!7T.+F[OKJ[O3B]N'QYNOV#GKXH#\8_^7O%_^7S]\2'V M/:?S].'VV[O5Z Q?%3H+NPF:2_1^=_/IKV+WA=(5.9=VP"(3]OGGFT\@7%]$ M[Y6_7]\]W%R>?PY^<*V9\*X>O/N/FZN'O^(0M6",PLT&/^\Q\:S8CT$F\'OZ MVPO[B8E]0G_H!NWWL:W"8ATG]T7R.F.WK2@J1(VW(RP(XWFH?-:PV6^3B8&G MGG]Z%DO.L1D6W!O/Y/DM1/\U4C46MK+<8JSV\L\UX3OQ6).%M2P)@ML5__1P M&9=^7JD23RS=XCSD_[(1+-')RCDHYV!B#K9@#M[XIXE\82!.0UPZ\!)-+,"P M63)1\)4G%+53:DV3*GOIK7@V*(M%\>;^,N;71ZSZIZY\NU2#R<.<\G>N53F$5P,RA MQW/\%O6 Y6I0<^%)+U5G2/H"80^V7/;]!/,F8RMT@%NAXCFUO\YU6.%A,E^G M46!3-[E!JX?W\PE+]=A609"+[@,5^+N62TC@Y=5+J. G?XF=2K\^.@C5X8D@ M8J +!WO1[!B1L8;Z+%9K>WA:[T?RXM$8B](UPR6VR1D-EO2.Y=EC_W1QBH=K ML);&HZ-_L4SV:)+XC041BQ7M+&#_0%U26&DG3JF"IDXD4#TNBK:<>ELQOF/- MMEFI3'A"ZV]<^^@4RQ)8.5!?4,X 2L$VQV9AX5.8" ^J 5_BZ21^%ZF*$RIQ M<,;P!,[Z%#5+,5E%(?_!\M->;(]79]1?+?;."0N'E^PHZT%[E8>3E4H\N+4L M.#QT4>*QDC,+DP/X8:$;X(/Z>=J$Y80%N\8I>>.^%PI:%G+$>5$:SK;("/.= MTB"Q(H+QP!?#?'E#>Q$6JR+6QXBM3/EI& ^D>$)\1&GR#4QHMYTEQWK"%JYF M&-8+BPJH$TF$=<'/[_AC-$"O"*W1U&(X.C\)*Z:"V!%^WP.[<0CN)"SCFLT, MZN_3LZ%S>#+,1,@XZL3/N7.L4-[QMM]D[,R'B*4E#+_*]&LG^8%,;/;99&P] MFNQ4.*-X;&F9!KH^!OR$AQE^6TP_\6##P4-='F@))S4,,LOAYR9ITUAL)?DN MI@^S.1K6!R+H#D-;2,Q._CW#X.'& 'RK>18, 5]H^;/+41X14X2E)V,EY:E M02-Q8M]@^$9X^SQGGY@08_*X.I(YDS&OGN/9J@B0%=7*L.PE/ FC/(^L]E-T M[QS-LG!\AL + !'Z X^L/.HNDCC2HSE0CQ9)O0E& \ZCJ_V3J0#_JM^=HO_ MY?@)X4."BJM(1U O_/(N_IN.*W4&/X)!8JS(B;\T%SO> T79=UL>&F,$S29H M-DN0<1)OS/E_-\' Z=85 ^?@\7@E1$R=1T)"Q$B(& D1(R%B]@HB9N]BHYQX M)AD%?7?([22$:5DCVND=1[2S++2HM\L-@Q^)Q[/E0$?B\1P!'L_^.(>XF5^X M-0J"$+S.'/X1D' V7PGWC\,W[-M*6&(?U6 T)/:1Q#Z2V$<2^TAB'^T&^VA_ M8K="T5DRI&-7<#),(A$OYG;F'YGD^:^$^)5Z;Q&N3 M>&T2KZU.,UKBM4E@&XG7)O':Y!SU6[])_':CCUE M4.*U2;PVB=1>(N5) MI#R)E"<=N43*DTAY$BEO_QW-D2#E[4_TO2R(3@;;,,@"W$0,N*RLA)_6<03A M>UYU(J$*:SU.$JIP^S9T5=N8M*W7FFW"F\XW8K/JADV,:+NN1K2$78L1?FJG MKM/\&/W-9\MQ?E5 D J3)!NQT4'8H-I;'@2E&BO$UV7EC<&& L)LQ<&A8-O: M8 ,\_^B1U4*A-3#9+CH?/OZ.7__]0NCC$TO=YI7%BNFQNG+,RL86G: >*ZKT M\ERP*"9K5N>G5FS!QS%BE"MJL-X7>ZP/E'X!Y%$A:/+.:<+P[' #+SW 1("NJ. MBR-M!M:"QB$\C#HHXPU&8>;9XR>- M'_C5=U+UNPO@(WMD$UHI<"VI%J%H27DQR^''"]NW'1JL1$X#J[#/*ZNE*Z/D M$NJSI9G.5\2+?K UG9R;^BT>V-^QPA1LUXG*8C997G4.;WFU;+?'<6$E^XA_ M=5*77$S:2B1A-H;12_6WQQF^HTPK%AF96DHA693-LJLL/.IDRQXVR'8XR(G: MH AJJLR(@6? ?F:9M_$0 @,(/Q<739.0Z"NF0H<"$AX?H"'STW+ M2$XD;/^O)OL_18U2IQ?SD+FX'O[Y&6CG^.9Q\;(:< ="O1?%9O)5@-?;N[#U M!2U=S)^&,7.MJ?_@/WP>.DW@E[F$WT^ZZE]BEHL=D>(^HG*EN631V>1F.N-> M)+'786YS9E)XR3 +Z;RL-I [Y;;]EQ/4>=!J4-S6 NMAT!') **/Z ]TB&PC MSG[+7GWS/;C6X5W\ZNKFZZ>@RJL;1*6UDT1K411JM]OH=-7::X%4W'OT+UKHE+G[#_JVH)%FT8JIW=NNW"?.ZG12MO&,MFKSK;52+/*<:I MW>TWAO[V?)T'5.JKU->=.M,Z:&I-G.G*T=2:SK35DVO@;>]95S30VQ= C183 MJRV)6]%QO]1YJ?/'H/-RA;Q[IU[M"GF/0O%=&K8VS&O=\D;8_^Y'> ?;@2O* MI4:KF#)W#'OM0:.]NVUQ.57D5*FEL.H4.M1ADF0 5:21;= 3.TRZO8I)_W6 M5!*'_7%H.9;"P1 H\-)%A>-062Y1M$>;\#)3\>[-!_S]*_P>NX 3("6YR M(9IM4%Y#]D;]5?E(1K:'>#MJFXU1OX&P&F\H_94];8TY+!F_$LT'%%'P_G1V M_QBBS$T8X+T/(Q(.7;Q_!K_'V=(P9]VQ3,V([M<-_7_Z,@]N%GC1G,2EOE^N+A2LK35\>;IX=0N7)V9CHFR! MFH@NQC''/F'7B%HOO"?A"=Z5QA+^%_2?7\H<@ ]EC7D#Y5:R D;)"+%K@H6[ M]8(Y%J&DL,)N-XU%?VS89 FO:X!GL&20LU/N[#=@YHU!4B UG M6B@8_P8@/8)_2JIA)#I!@WS\R7E4(&6Y\#63G2_. 'T27#5'O)E:MON(59]X MUZ,_\Q ,BEWC $/T!A\7^/_B/Q^;![$;>XD2/,.F0H@S!0WCE4>!N@:W 8R M<;R10_[T>%D_FR/X$CZQ('*$6 D$DNP[A$IA-R'YQ?LC_K >2L$IU;T/8NKR M%U8OHYFF-TT2QT$:D+X4XT:80E5H,1G O.+34\\ MF^%J"ETL'KVPBU&91K/[5J+!+M?RMA9+W-BU-8+YB"LDC6G>?_H-H !\,VPP MO[K@S-CM,/#48HF7?SGW(ZCXH^;?/1&WYQ%@GFCM=NBPQ&V"T&$M+ACVIN)L MK4*RA1NYQT]$]PQR._%Q07B+K&UH\2/'/S$?HU8WJ4GK'D]-6KU-9SVID@5> MLL!+%GAM[P"TSH4^LL#K.,==%GC5[JQ;%GC5(_6A#NS)VA=9X"657"KY/IY! MUT&]:^+298'705@T63 C"[RDOAZSOLJ$KMT[4UG@5:-$5UGLF\7"'OWJG+ J\:c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end